Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Tuberculosis

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 660 articles:
HTML format
Text format



Single Articles


    January 2019
  1. ZEGEYE A, Dessie G, Wagnew F, Gebrie A, et al
    Prevalence and determinants of anti-tuberculosis treatment non-adherence in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0210422.
    PubMed     Text format     Abstract available


  2. OHENE SA, Bakker MI, Ojo J, Toonstra A, et al
    Extra-pulmonary tuberculosis: A retrospective study of patients in Accra, Ghana.
    PLoS One. 2019;14:e0209650.
    PubMed     Text format     Abstract available


  3. OLLINGER J, Kumar A, Roberts DM, Bailey MA, et al
    A high-throughput whole cell screen to identify inhibitors of Mycobacterium tuberculosis.
    PLoS One. 2019;14:e0205479.
    PubMed     Text format     Abstract available



  4. Correction: Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda.
    PLoS One. 2019;14:e0210769.
    PubMed     Text format     Abstract available


  5. CHEN YT, Kuo SC, Chao PW, Chang YY, et al
    Use of lipid-lowering agents is not associated with improved outcomes for tuberculosis patients on standard-course therapy: A population-based cohort study.
    PLoS One. 2019;14:e0210479.
    PubMed     Text format     Abstract available


  6. ROMANOWSKI K, Campbell JR, Oxlade O, Fregonese F, et al
    The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: A modelling study.
    PLoS One. 2019;14:e0211355.
    PubMed     Text format     Abstract available



  7. Retraction: PknE, a Serine/Threonine Protein Kinase of Mycobacterium tuberculosis Initiates Survival Crosstalk That Also Impacts HIV Coinfection.
    PLoS One. 2019;14:e0211247.
    PubMed     Text format    


  8. BHATTACHARYA CHAKRAVARTY A, Rangan S, Dholakia Y, Rai S, et al
    Such a long journey: What health seeking pathways of patients with drug resistant tuberculosis in Mumbai tell us.
    PLoS One. 2019;14:e0209924.
    PubMed     Text format     Abstract available


  9. BOGDANOVA EN, Mariandyshev AO, Balantcev GA, Eliseev PI, et al
    Cost minimization analysis of line probe assay for detection of multidrug-resistant tuberculosis in Arkhangelsk region of Russian Federation.
    PLoS One. 2019;14:e0211203.
    PubMed     Text format     Abstract available


  10. GUERRA J, Mogollon D, Gonzalez D, Sanchez R, et al
    Active and latent tuberculosis among inmates in La Esperanza prison in Guaduas, Colombia.
    PLoS One. 2019;14:e0209895.
    PubMed     Text format     Abstract available



  11. Correction: Kenya tuberculosis prevalence survey 2016: Challenges and opportunities of ending TB in Kenya.
    PLoS One. 2019;14:e0211593.
    PubMed     Text format     Abstract available


  12. ALOTAIBI B, Yassin Y, Mushi A, Maashi F, et al
    Tuberculosis knowledge, attitude and practice among healthcare workers during the 2016 Hajj.
    PLoS One. 2019;14:e0210913.
    PubMed     Text format     Abstract available


  13. HIPPNER P, Sumner T, Houben RM, Cardenas V, et al
    Application of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South Africa.
    PLoS One. 2019;14:e0209320.
    PubMed     Text format     Abstract available


  14. ZHANG F, Xu C, Ning L, Hu F, et al
    Correction: Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis.
    PLoS One. 2019;14:e0212300.
    PubMed     Text format     Abstract available


  15. WOOD HN, Venken T, Willems H, Jacobs A, et al
    Molecular drug susceptibility testing and strain typing of tuberculosis by DNA hybridization.
    PLoS One. 2019;14:e0212064.
    PubMed     Text format     Abstract available


  16. MULONGENI P, Hermans S, Caldwell J, Bekker LG, et al
    HIV prevalence and determinants of loss-to-follow-up in adolescents and young adults with tuberculosis in Cape Town.
    PLoS One. 2019;14:e0210937.
    PubMed     Text format     Abstract available


  17. YIRDAW KD, Teklu AM, Mamuye AT, Zewdu S, et al
    Breakthrough tuberculosis disease among people with HIV - Should we be worried? A retrospective longitudinal study.
    PLoS One. 2019;14:e0211688.
    PubMed     Text format     Abstract available


  18. DJIMEU EW, Heard AC
    Treatment of HIV among tuberculosis patients: A replication study of timing of antiretroviral therapy for HIV-1-associated tuberculosis.
    PLoS One. 2019;14:e0210327.
    PubMed     Text format     Abstract available


  19. AFSHAR B, Carless J, Roche A, Balasegaram S, et al
    Surveillance of tuberculosis (TB) cases attributable to relapse or reinfection in London, 2002-2015.
    PLoS One. 2019;14:e0211972.
    PubMed     Text format     Abstract available


  20. RING SC, Purfield DC, Good M, Breslin P, et al
    Variance components for bovine tuberculosis infection and multi-breed genome-wide association analysis using imputed whole genome sequence data.
    PLoS One. 2019;14:e0212067.
    PubMed     Text format     Abstract available


  21. ROE WD, Lenting B, Kokosinska A, Hunter S, et al
    Pathology and molecular epidemiology of Mycobacterium pinnipedii tuberculosis in native New Zealand marine mammals.
    PLoS One. 2019;14:e0212363.
    PubMed     Text format     Abstract available


  22. DOULLA BE, Squire SB, MacPherson E, Ngadaya ES, et al
    Routine surveillance for the identification of drug resistant Tuberculosis in Tanzania: A cross-sectional study of stakeholders' perceptions.
    PLoS One. 2019;14:e0212421.
    PubMed     Text format     Abstract available


  23. REIS-SANTOS B, Shete P, Bertolde A, Sales CM, et al
    Tuberculosis in Brazil and cash transfer programs: A longitudinal database study of the effect of cash transfer on cure rates.
    PLoS One. 2019;14:e0212617.
    PubMed     Text format     Abstract available


  24. ADESOKAN HK, Streicher EM, van Helden PD, Warren RM, et al
    Genetic diversity of Mycobacterium tuberculosis complex strains isolated from livestock workers and cattle in Nigeria.
    PLoS One. 2019;14:e0211637.
    PubMed     Text format     Abstract available


  25. SOEROTO AY, Lestari BW, Santoso P, Chaidir L, et al
    Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study.
    PLoS One. 2019;14:e0213017.
    PubMed     Text format     Abstract available


  26. NGUYEN DT, Agarwal S, Graviss EA
    Trends of tuberculosis meningitis and associated mortality in Texas, 2010-2017, a large population-based analysis.
    PLoS One. 2019;14:e0212729.
    PubMed     Text format     Abstract available


  27. IWAMOTO T, Murase Y, Yoshida S, Aono A, et al
    Overcoming the pitfalls of automatic interpretation of whole genome sequencing data by online tools for the prediction of pyrazinamide resistance in Mycobacterium tuberculosis.
    PLoS One. 2019;14:e0212798.
    PubMed     Text format     Abstract available


  28. DENEGRE AA, Ndeffo Mbah ML, Myers K, Fefferman NH, et al
    Emergence of antibiotic resistance in immunocompromised host populations: A case study of emerging antibiotic resistant tuberculosis in AIDS patients.
    PLoS One. 2019;14:e0212969.
    PubMed     Text format     Abstract available


  29. GUALANO G, Mencarini P, Musso M, Mosti S, et al
    Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy.
    PLoS One. 2019;14:e0212948.
    PubMed     Text format     Abstract available


  30. LOPEZ-GARNIER S, Sheen P, Zimic M
    Automatic diagnostics of tuberculosis using convolutional neural networks analysis of MODS digital images.
    PLoS One. 2019;14:e0212094.
    PubMed     Text format     Abstract available


  31. LONG R, Asadi L, Heffernan C, Barrie J, et al
    Is there a fundamental flaw in Canada's post-arrival immigrant surveillance system for tuberculosis?
    PLoS One. 2019;14:e0212706.
    PubMed     Text format     Abstract available


  32. BACK YW, Choi S, Choi HG, Shin KW, et al
    Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses.
    PLoS One. 2019;14:e0213536.
    PubMed     Text format     Abstract available


  33. BADR MT, Hacker G
    Gene expression profiling meta-analysis reveals novel gene signatures and pathways shared between tuberculosis and rheumatoid arthritis.
    PLoS One. 2019;14:e0213470.
    PubMed     Text format     Abstract available


  34. NGUYEN DT, Phan H, Trinh T, Nguyen H, et al
    Sensitivity and characteristics associated with positive QuantiFERON-TB Gold-Plus assay in children with confirmed tuberculosis.
    PLoS One. 2019;14:e0213304.
    PubMed     Text format     Abstract available


  35. DA SILVA LF, Skupien EC, Lazzari TK, Holler SR, et al
    Advanced glycation end products (AGE) and receptor for AGE (RAGE) in patients with active tuberculosis, and their relationship between food intake and nutritional status.
    PLoS One. 2019;14:e0213991.
    PubMed     Text format     Abstract available


  36. SEIJGER C, Hoefsloot W, Bergsma-de Guchteneire I, Te Brake L, et al
    High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre.
    PLoS One. 2019;14:e0213718.
    PubMed     Text format     Abstract available


  37. NWANA N, Marks SM, Lan E, Chang AH, et al
    Treatment of latent Mycobacterium tuberculosis infection with 12 once weekly directly-observed doses of isoniazid and rifapentine among persons experiencing homelessness.
    PLoS One. 2019;14:e0213524.
    PubMed     Text format     Abstract available


  38. ANDRES M, van der Werf MJ, Kodmon C, Albrecht S, et al
    Molecular and genomic typing for tuberculosis surveillance: A survey study in 26 European countries.
    PLoS One. 2019;14:e0210080.
    PubMed     Text format     Abstract available


  39. LEE HJ, Ko HJ, Kim SH, Jung YJ, et al
    Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages.
    PLoS One. 2019;14:e0199799.
    PubMed     Text format     Abstract available


  40. HWANG B, Shroufi A, Gils T, Steele SJ, et al
    Stock-outs of antiretroviral and tuberculosis medicines in South Africa: A national cross-sectional survey.
    PLoS One. 2019;14:e0212405.
    PubMed     Text format     Abstract available


  41. SUMI A, Kobayashi N
    Time-series analysis of geographically specific monthly number of newly registered cases of active tuberculosis in Japan.
    PLoS One. 2019;14:e0213856.
    PubMed     Text format     Abstract available


  42. ZHANG C, Xia L, Rainey JJ, Li Y, et al
    Findings from a pilot project to assess the feasibility of active tuberculosis case finding among seniors in rural Sichuan Province, China, 2017.
    PLoS One. 2019;14:e0214761.
    PubMed     Text format     Abstract available


  43. HOYT KJ, Sarkar S, White L, Joseph NM, et al
    Effect of malnutrition on radiographic findings and mycobacterial burden in pulmonary tuberculosis.
    PLoS One. 2019;14:e0214011.
    PubMed     Text format     Abstract available


  44. AL-GHAFLI H, Varghese B, Enani M, Alrajhi A, et al
    Demographic risk factors for extra-pulmonary tuberculosis among adolescents and adults in Saudi Arabia.
    PLoS One. 2019;14:e0213846.
    PubMed     Text format     Abstract available


  45. VON STREIT F, Bartels C, Kuczius T, Cassier C, et al
    Prevalence of latent tuberculosis in homeless persons: A single-centre cross-sectional study, Germany.
    PLoS One. 2019;14:e0214556.
    PubMed     Text format     Abstract available


  46. WOOD A, Barizuddin S, Darr CM, Mathai CJ, et al
    Ultrasensitive detection of lipoarabinomannan with plasmonic grating biosensors in clinical samples of HIV negative patients with tuberculosis.
    PLoS One. 2019;14:e0214161.
    PubMed     Text format     Abstract available


  47. ANAND S, Ganaie AA, Sharma C
    Differential thermal stability, conformational stability and unfolding behavior of Eis proteins from Mycobacterium smegmatis and Mycobacterium tuberculosis.
    PLoS One. 2019;14:e0213933.
    PubMed     Text format     Abstract available


  48. BORRELL S, Trauner A, Brites D, Rigouts L, et al
    Reference set of Mycobacterium tuberculosis clinical strains: A tool for research and product development.
    PLoS One. 2019;14:e0214088.
    PubMed     Text format     Abstract available


  49. HENRARD S, Corbiere V, Schandene L, Ducarme M, et al
    Proportions of interferon-gamma-producing ascites lymphocytes in response to mycobacterial antigens: A help for early diagnosis of peritoneal tuberculosis in a low TB incidence country.
    PLoS One. 2019;14:e0214333.
    PubMed     Text format     Abstract available


  50. GUTHRIE JL, Marchand-Austin A, Cronin K, Lam K, et al
    Universal genotyping reveals province-level differences in the molecular epidemiology of tuberculosis.
    PLoS One. 2019;14:e0214870.
    PubMed     Text format     Abstract available


  51. SHIMELES E, Enquselassie F, Aseffa A, Tilahun M, et al
    Risk factors for tuberculosis: A case-control study in Addis Ababa, Ethiopia.
    PLoS One. 2019;14:e0214235.
    PubMed     Text format     Abstract available


  52. LEE PH, Chan PC, Peng YT, Chu PW, et al
    Impact of universal drug susceptibility testing and effective management of multidrug-resistant tuberculosis in Taiwan.
    PLoS One. 2019;14:e0214792.
    PubMed     Text format     Abstract available


  53. SARIN S, Huddart S, Raizada N, Parija D, et al
    Cost and operational impact of promoting upfront GeneXpert MTB/RIF test referrals for presumptive pediatric tuberculosis patients in India.
    PLoS One. 2019;14:e0214675.
    PubMed     Text format     Abstract available


  54. DHIMAN RK, Pujari V, Kincaid JM, Ikeh MA, et al
    Characterization of MenA (isoprenyl diphosphate:1,4-dihydroxy-2-naphthoate isoprenyltransferase) from Mycobacterium tuberculosis.
    PLoS One. 2019;14:e0214958.
    PubMed     Text format     Abstract available


  55. RUTAIHWA LK, Sasamalo M, Jaleco A, Hella J, et al
    Insights into the genetic diversity of Mycobacterium tuberculosis in Tanzania.
    PLoS One. 2019;14:e0206334.
    PubMed     Text format     Abstract available


  56. JAGANATH D, Wobudeya E, Sekadde MP, Nsangi B, et al
    Seasonality of childhood tuberculosis cases in Kampala, Uganda, 2010-2015.
    PLoS One. 2019;14:e0214555.
    PubMed     Text format     Abstract available


  57. GOODELL AJ, Shete PB, Vreman R, McCabe D, et al
    Outlook for tuberculosis elimination in California: An individual-based stochastic model.
    PLoS One. 2019;14:e0214532.
    PubMed     Text format     Abstract available


  58. BROGER T, Tsionksy M, Mathew A, Lowary TL, et al
    Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients.
    PLoS One. 2019;14:e0215443.
    PubMed     Text format     Abstract available


  59. MARTIN-SANCHEZ M, Brugueras S, de Andres A, Simon P, et al
    Tuberculosis incidence among infected contacts detected through contact tracing of smear-positive patients.
    PLoS One. 2019;14:e0215322.
    PubMed     Text format     Abstract available


  60. JO EJ, Park S, Lee KM, Kim I, et al
    Time to appropriate treatment in patients with multidrug-resistant tuberculosis in South Korea: Are we still in 2010?
    PLoS One. 2019;14:e0216084.
    PubMed     Text format     Abstract available


  61. OGA-OMENKA C, Zarowsky C, Agbaje A, Kuye J, et al
    Rates and timeliness of treatment initiation among drug-resistant tuberculosis patients in Nigeria- A retrospective cohort study.
    PLoS One. 2019;14:e0215542.
    PubMed     Text format     Abstract available


  62. CUI Z, Lin D, Chongsuvivatwong V, Zhao J, et al
    Spatiotemporal patterns and ecological factors of tuberculosis notification: A spatial panel data analysis in Guangxi, China.
    PLoS One. 2019;14:e0212051.
    PubMed     Text format     Abstract available


  63. GUTHRIE JL, Ronald LA, Cook VJ, Johnston J, et al
    The problem with defining foreign birth as a risk factor in tuberculosis epidemiology studies.
    PLoS One. 2019;14:e0216271.
    PubMed     Text format     Abstract available


  64. DATTA S, Alvarado K, Gilman RH, Valencia T, et al
    Optimising fluorescein diacetate sputum smear microscopy for assessing patients with pulmonary tuberculosis.
    PLoS One. 2019;14:e0214131.
    PubMed     Text format     Abstract available


  65. MOGASHOA T, Melamu P, Ley SD, Streicher EM, et al
    Genetic diversity of Mycobacterium tuberculosis strains circulating in Botswana.
    PLoS One. 2019;14:e0216306.
    PubMed     Text format     Abstract available


  66. COHEN DB, Davies G, Malwafu W, Mangochi H, et al
    Poor outcomes in recurrent tuberculosis: More than just drug resistance?
    PLoS One. 2019;14:e0215855.
    PubMed     Text format     Abstract available


  67. YUEN CM, Millones AK, Contreras CC, Lecca L, et al
    Tuberculosis household accompaniment to improve the contact management cascade: A prospective cohort study.
    PLoS One. 2019;14:e0217104.
    PubMed     Text format     Abstract available


  68. CROSS GB, Yeo BC, Hutchinson PE, Tan MC, et al
    Impact of selective immune-cell depletion on growth of Mycobacterium tuberculosis (Mtb) in a whole-blood bactericidal activity (WBA) assay.
    PLoS One. 2019;14:e0216616.
    PubMed     Text format     Abstract available


  69. CHOI H, Chung H, Muntaner C
    Social selection in historical time: The case of tuberculosis in South Korea after the East Asian financial crisis.
    PLoS One. 2019;14:e0217055.
    PubMed     Text format     Abstract available


  70. GABRIELIAN A, Engle E, Harris M, Wollenberg K, et al
    TB DEPOT (Data Exploration Portal): A multi-domain tuberculosis data analysis resource.
    PLoS One. 2019;14:e0217410.
    PubMed     Text format     Abstract available


  71. GUPTE AN, Paradkar M, Selvaraju S, Thiruvengadam K, et al
    Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD.
    PLoS One. 2019;14:e0217289.
    PubMed     Text format     Abstract available


  72. MCKAY B, Castellanos M, Ebell M, Whalen CC, et al
    An attempt to reproduce a previous meta-analysis and a new analysis regarding the impact of directly observed therapy on tuberculosis treatment outcomes.
    PLoS One. 2019;14:e0217219.
    PubMed     Text format     Abstract available


  73. THEE S, Kruger R, von Bernuth H, Meisel C, et al
    Screening and treatment for tuberculosis in a cohort of unaccompanied minor refugees in Berlin, Germany.
    PLoS One. 2019;14:e0216234.
    PubMed     Text format     Abstract available


  74. RODRIGUEZ-FLORES EM, Mata-Espinosa D, Barrios-Payan J, Marquina-Castillo B, et al
    A significant therapeutic effect of silymarin administered alone, or in combination with chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains: In vitro and in vivo studies.
    PLoS One. 2019;14:e0217457.
    PubMed     Text format     Abstract available


  75. MEKONNEN B, Mihret A, Getahun M, Hailu T, et al
    Evaluation of the tuberculosis culture color plate test for rapid detection of drug susceptible and drug-resistant Mycobacterium tuberculosis in a resource-limited setting, Addis Ababa, Ethiopia.
    PLoS One. 2019;14:e0215679.
    PubMed     Text format     Abstract available


  76. MUTTAMBA W, Ssengooba W, Kirenga B, Sekibira R, et al
    Health seeking behavior among individuals presenting with chronic cough at referral hospitals in Uganda; Missed opportunity for early tuberculosis diagnosis.
    PLoS One. 2019;14:e0217900.
    PubMed     Text format     Abstract available


  77. VAN RENSBURG C, Berhanu R, Hirasen K, Evans D, et al
    Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa.
    PLoS One. 2019;14:e0217820.
    PubMed     Text format     Abstract available


  78. SHAMU S, Kuwanda L, Farirai T, Guloba G, et al
    Study on knowledge about associated factors of Tuberculosis (TB) and TB/HIV co-infection among young adults in two districts of South Africa.
    PLoS One. 2019;14:e0217836.
    PubMed     Text format     Abstract available


  79. MADRAZO-MOYA CF, Cancino-Munoz I, Cuevas-Cordoba B, Gonzalez-Covarrubias V, et al
    Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico.
    PLoS One. 2019;14:e0213046.
    PubMed     Text format     Abstract available


  80. DEO S, Jindal P, Gupta D, Khaparde S, et al
    What would it cost to scale-up private sector engagement efforts for tuberculosis care? Evidence from three pilot programs in India.
    PLoS One. 2019;14:e0214928.
    PubMed     Text format     Abstract available


  81. SPAGGIARI D, Desfontaine V, Cruchon S, Guinchard S, et al
    Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and five active metabolites in human plasma.
    PLoS One. 2019;14:e0217139.
    PubMed     Text format     Abstract available


  82. HUANG F, Li W, Xu H, Qin H, et al
    Cordycepin kills Mycobacterium tuberculosis through hijacking the bacterial adenosine kinase.
    PLoS One. 2019;14:e0218449.
    PubMed     Text format     Abstract available


  83. SAKTIAWATI AMI, Stienstra Y, Subronto YW, Rintiswati N, et al
    Sensitivity and specificity of an electronic nose in diagnosing pulmonary tuberculosis among patients with suspected tuberculosis.
    PLoS One. 2019;14:e0217963.
    PubMed     Text format     Abstract available


  84. MIN J, Chung C, Jung SS, Park HK, et al
    Understanding illness perception in pulmonary tuberculosis patients: One step towards patient-centered care.
    PLoS One. 2019;14:e0218106.
    PubMed     Text format     Abstract available


  85. GLASAUER S, Altmann D, Hauer B, Brodhun B, et al
    First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017.
    PLoS One. 2019;14:e0217597.
    PubMed     Text format     Abstract available


  86. ONWUBIKO U, Wall K, Sales RM, Holland DP, et al
    Using Directly Observed Therapy (DOT) for latent tuberculosis treatment - A hit or a miss? A propensity score analysis of treatment completion among 274 homeless adults in Fulton County, GA.
    PLoS One. 2019;14:e0218373.
    PubMed     Text format     Abstract available


  87. WAGSTAFF A, van Doorslaer E, Burger R
    SMS nudges as a tool to reduce tuberculosis treatment delay and pretreatment loss to follow-up. A randomized controlled trial.
    PLoS One. 2019;14:e0218527.
    PubMed     Text format     Abstract available


  88. TOLA HH, Holakouie-Naieni K, Lejisa T, Mansournia MA, et al
    Is hypothyroidism rare in multidrug resistance tuberculosis patients on treatment? A systematic review and meta-analysis.
    PLoS One. 2019;14:e0218487.
    PubMed     Text format     Abstract available


  89. AUNG YK, Swe PP, Kyaw Z, Thein ST, et al
    Differential loss to follow-up rates among adult tuberculosis patients - Findings from the largest private sector tuberculosis clinic database in Myanmar.
    PLoS One. 2019;14:e0218450.
    PubMed     Text format     Abstract available


  90. YOUNIS H, Kerschbaumer I, Moon JY, Kim RS, et al
    Combining urine lipoarabinomannan with antibody detection as a simple non-sputum-based screening method for HIV-associated tuberculosis.
    PLoS One. 2019;14:e0218606.
    PubMed     Text format     Abstract available


  91. DAMENA D, Tolosa S, Hailemariam M, Zewude A, et al
    Genetic diversity and drug susceptibility profiles of Mycobacterium tuberculosis obtained from Saint Peter's TB specialized Hospital, Ethiopia.
    PLoS One. 2019;14:e0218545.
    PubMed     Text format     Abstract available


  92. SEGAFREDO G, Kapur A, Robbiati C, Joseph N, et al
    Integrating TB and non-communicable diseases services: Pilot experience of screening for diabetes and hypertension in patients with Tuberculosis in Luanda, Angola.
    PLoS One. 2019;14:e0218052.
    PubMed     Text format     Abstract available


  93. LEE DJ, Kumarasamy N, Resch SC, Sivaramakrishnan GN, et al
    Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India's public sector.
    PLoS One. 2019;14:e0218890.
    PubMed     Text format     Abstract available


  94. TUOT S, Teo AKJ, Cazabon D, Sok S, et al
    Acceptability of active case finding with a seed-and-recruit model to improve tuberculosis case detection and linkage to treatment in Cambodia: A qualitative study.
    PLoS One. 2019;14:e0210919.
    PubMed     Text format     Abstract available


  95. SPRUIJT I, Erkens C, Suurmond J, Huisman E, et al
    Implementation of latent tuberculosis infection screening and treatment among newly arriving immigrants in the Netherlands: A mixed methods pilot evaluation.
    PLoS One. 2019;14:e0219252.
    PubMed     Text format     Abstract available


  96. BARCELLINI L, Borroni E, Cimaglia C, Girardi E, et al
    App-based symptoms screening with Xpert MTB/RIF Ultra assay used for active tuberculosis detection in migrants at point of arrivals in Italy: The E-DETECT TB intervention analysis.
    PLoS One. 2019;14:e0218039.
    PubMed     Text format     Abstract available


  97. COUVIN D, Reynaud Y, Rastogi N
    Two tales: Worldwide distribution of Central Asian (CAS) versus ancestral East-African Indian (EAI) lineages of Mycobacterium tuberculosis underlines a remarkable cleavage for phylogeographical, epidemiological and demographical characteristics.
    PLoS One. 2019;14:e0219706.
    PubMed     Text format     Abstract available


  98. BAIK Y, Fane O, Wang Q, Modongo C, et al
    Undetected tuberculosis at enrollment and after hospitalization in medical and oncology wards in Botswana.
    PLoS One. 2019;14:e0219678.
    PubMed     Text format     Abstract available


  99. ABDULLAHI OA, Ngari MM, Sanga D, Katana G, et al
    Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya.
    PLoS One. 2019;14:e0219191.
    PubMed     Text format     Abstract available


  100. SARKAR S, Rivas-Santiago CE, Ibironke OA, Carranza C, et al
    Season and size of urban particulate matter differentially affect cytotoxicity and human immune responses to Mycobacterium tuberculosis.
    PLoS One. 2019;14:e0219122.
    PubMed     Text format     Abstract available


  101. DE SCHACHT C, Mutaquiha C, Faria F, Castro G, et al
    Barriers to access and adherence to tuberculosis services, as perceived by patients: A qualitative study in Mozambique.
    PLoS One. 2019;14:e0219470.
    PubMed     Text format     Abstract available


  102. KINIKAR A, Chandanwale A, Kadam D, Joshi S, et al
    High risk for latent tuberculosis infection among medical residents and nursing students in India.
    PLoS One. 2019;14:e0219131.
    PubMed     Text format     Abstract available


  103. MAVE V, Chandrasekaran P, Chavan A, Shivakumar SVBY, et al
    Infection free "resisters" among household contacts of adult pulmonary tuberculosis.
    PLoS One. 2019;14:e0218034.
    PubMed     Text format     Abstract available


  104. DIAZ-HUERTA JL, Tellez-Anguiano ADC, Fraga-Aguilar M, Gutierrez-Gnecchi JA, et al
    Image processing for AFB segmentation in bacilloscopies of pulmonary tuberculosis diagnosis.
    PLoS One. 2019;14:e0218861.
    PubMed     Text format     Abstract available


  105. GOTO A, Komiya K, Kan T, Honjo K, et al
    Factors associated with atypical radiological findings of pulmonary tuberculosis.
    PLoS One. 2019;14:e0220346.
    PubMed     Text format     Abstract available


  106. OGBUABOR DC, Okoronkwo IL
    The influence of quality of work life on motivation and retention of local government tuberculosis control programme supervisors in South-eastern Nigeria.
    PLoS One. 2019;14:e0220292.
    PubMed     Text format     Abstract available


  107. BEN AYED H, Koubaa M, Gargouri L, Ben Jemaa M, et al
    Epidemiology and disease burden of tuberculosis in south of Tunisia over a 22-year period: Current trends and future projections.
    PLoS One. 2019;14:e0212853.
    PubMed     Text format     Abstract available


  108. DRABAREK D, Anh NT, Nhung NV, Hoa NB, et al
    Implementation of Medication Event Reminder Monitors among patients diagnosed with drug susceptible tuberculosis in rural Viet Nam: A qualitative study.
    PLoS One. 2019;14:e0219891.
    PubMed     Text format     Abstract available


  109. YEWARE A, Gample S, Agrawal S, Sarkar D, et al
    Using diphenyleneiodonium to induce a viable but non-culturable phenotype in Mycobacterium tuberculosis and its metabolomics analysis.
    PLoS One. 2019;14:e0220628.
    PubMed     Text format     Abstract available


  110. THOMAS BE, Thiruvengadam K, S R, Kadam D, et al
    Smoking, alcohol use disorder and tuberculosis treatment outcomes: A dual co-morbidity burden that cannot be ignored.
    PLoS One. 2019;14:e0220507.
    PubMed     Text format     Abstract available



  111. Retraction: Surgical Management for Thoracic Spinal Tuberculosis Posterior Only versus Anterior Video-Assisted Thoracoscopic Surgery.
    PLoS One. 2019;14:e0220752.
    PubMed     Text format    


  112. TANUE EA, Nsagha DS, Njamen TN, Assob NJC, et al
    Tuberculosis treatment outcome and its associated factors among people living with HIV and AIDS in Fako Division of Cameroon.
    PLoS One. 2019;14:e0218800.
    PubMed     Text format     Abstract available


  113. BHATNAGAR T, Ralte M, Ralte L, Chawnglungmuana, et al
    Intensified tuberculosis and HIV surveillance in a prison in Northeast India: Implementation research.
    PLoS One. 2019;14:e0219988.
    PubMed     Text format     Abstract available


  114. ALELIGN A, Petros B, Ameni G
    Smear positive tuberculosis and genetic diversity of M. tuberculosis isolates in individuals visiting health facilities in South Gondar Zone, northwest Ethiopia.
    PLoS One. 2019;14:e0216437.
    PubMed     Text format     Abstract available


  115. BENNASRALLAH C, Kacem M, Dhouib W, Zemni I, et al
    BCG vaccination and tuberculosis prevention: A forty years cohort study, Monastir, Tunisia.
    PLoS One. 2019;14:e0219991.
    PubMed     Text format     Abstract available


  116. SABRI A, Quistrebert J, Naji Amrani H, Abid A, et al
    Prevalence and risk factors for latent tuberculosis infection among healthcare workers in Morocco.
    PLoS One. 2019;14:e0221081.
    PubMed     Text format     Abstract available


  117. FLORES-TREVINO S, Rodriguez-Noriega E, Garza-Gonzalez E, Gonzalez-Diaz E, et al
    Clinical predictors of drug-resistant tuberculosis in Mexico.
    PLoS One. 2019;14:e0220946.
    PubMed     Text format     Abstract available


  118. ANTHWAL D, Lavania S, Gupta RK, Verma A, et al
    Development and evaluation of novel bio-safe filter paper-based kits for sputum microscopy and transport to directly detect Mycobacterium tuberculosis and associated drug resistance.
    PLoS One. 2019;14:e0220967.
    PubMed     Text format     Abstract available


  119. ALENE KA, Clements ACA
    Spatial clustering of notified tuberculosis in Ethiopia: A nationwide study.
    PLoS One. 2019;14:e0221027.
    PubMed     Text format     Abstract available


  120. SHEN Y, Yu G, Zhong F, Kong X, et al
    Diagnostic accuracy of the Xpert MTB/RIF assay for bone and joint tuberculosis: A meta-analysis.
    PLoS One. 2019;14:e0221427.
    PubMed     Text format     Abstract available


  121. PUGA MAM, Bandeira LM, Pompilio MA, Rezende GR, et al
    Screening for HBV, HCV, HIV and syphilis infections among bacteriologically confirmed tuberculosis prisoners: An urgent action required.
    PLoS One. 2019;14:e0221265.
    PubMed     Text format     Abstract available


  122. SIDDIQUI S, Brooks MB, Malik AA, Fuad J, et al
    Evaluation of GenoType MTBDRplus for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Karachi, Pakistan.
    PLoS One. 2019;14:e0221485.
    PubMed     Text format     Abstract available


  123. CHU KA, Hsu CH, Lin MC, Chu YH, et al
    Association of iron deficiency anemia with tuberculosis in Taiwan: A nationwide population-based study.
    PLoS One. 2019;14:e0221908.
    PubMed     Text format     Abstract available


  124. SANCHEZ-MONTALVA A, Barios M, Salvador F, Villar A, et al
    Usefulness of FDG PET/CT in the management of tuberculosis.
    PLoS One. 2019;14:e0221516.
    PubMed     Text format     Abstract available


  125. CHARYEVA Z, Curtis S, Mullen S, Senik T, et al
    What works best for ensuring treatment adherence. Lessons from a social support program for people treated for tuberculosis in Ukraine.
    PLoS One. 2019;14:e0221688.
    PubMed     Text format     Abstract available


  126. ZHANG J, Zhao Z, Bai H, Wang M, et al
    Genetic polymorphisms in PXR and NF-kappaB1 influence susceptibility to anti-tuberculosis drug-induced liver injury.
    PLoS One. 2019;14:e0222033.
    PubMed     Text format     Abstract available


  127. VAN HOOFT P, Getz WM, Greyling BJ, Bastos ADS, et al
    A natural gene drive system influences bovine tuberculosis susceptibility in African buffalo: Possible implications for disease management.
    PLoS One. 2019;14:e0221168.
    PubMed     Text format     Abstract available


  128. OLIWA JN, Gathara D, Ogero M, van Hensbroek MB, et al
    Diagnostic practices and estimated burden of tuberculosis among children admitted to 13 government hospitals in Kenya: An analysis of two years' routine clinical data.
    PLoS One. 2019;14:e0221145.
    PubMed     Text format     Abstract available


  129. HARRIS M, Qi A, Jeagal L, Torabi N, et al
    A systematic review of the diagnostic accuracy of artificial intelligence-based computer programs to analyze chest x-rays for pulmonary tuberculosis.
    PLoS One. 2019;14:e0221339.
    PubMed     Text format     Abstract available


  130. FANTAHUN M, Kebede A, Yenew B, Gemechu T, et al
    Diagnostic accuracy of Xpert MTB/RIF assay and non-molecular methods for the diagnosis of tuberculosis lymphadenitis.
    PLoS One. 2019;14:e0222402.
    PubMed     Text format     Abstract available


  131. WAMPANDE EM, Naniima P, Mupere E, Kateete DP, et al
    Genetic variability and consequence of Mycobacterium tuberculosis lineage 3 in Kampala-Uganda.
    PLoS One. 2019;14:e0221644.
    PubMed     Text format     Abstract available



  132. Retraction: Analysis of Mycobacterium tuberculosis-Specific CD8 T-Cells in Patients with Active Tuberculosis and in Individuals with Latent Infection.
    PLoS One. 2019;14:e0223028.
    PubMed     Text format    


  133. HAN SS, Lee SJ, Yim JJ, Song JH, et al
    Evaluation and treatment of latent tuberculosis infection among healthcare workers in Korea: A multicentre cohort analysis.
    PLoS One. 2019;14:e0222810.
    PubMed     Text format     Abstract available



  134. Correction: Low Dose Aerosol Fitness at the Innate Phase of Murine Infection Better Predicts Virulence amongst Clinical Strains of Mycobacterium tuberculosis.
    PLoS One. 2019;14:e0222794.
    PubMed     Text format     Abstract available


  135. NARANG A, Garima K, Porwal S, Bhandekar A, et al
    Potential impact of efflux pump genes in mediating rifampicin resistance in clinical isolates of Mycobacterium tuberculosis from India.
    PLoS One. 2019;14:e0223163.
    PubMed     Text format     Abstract available


  136. HAMID M, Brooks MB, Madhani F, Ali H, et al
    Risk factors for unsuccessful tuberculosis treatment outcomes in children.
    PLoS One. 2019;14:e0222776.
    PubMed     Text format     Abstract available


  137. KU CC, Dodd PJ
    Forecasting the impact of population ageing on tuberculosis incidence.
    PLoS One. 2019;14:e0222937.
    PubMed     Text format     Abstract available


  138. RICHOMME C, Courcoul A, Moyen JL, Reveillaud E, et al
    Tuberculosis in the wild boar: Frequentist and Bayesian estimations of diagnostic test parameters when Mycobacterium bovis is present in wild boars but at low prevalence.
    PLoS One. 2019;14:e0222661.
    PubMed     Text format     Abstract available


  139. ROSSETTO M, Brand EM, Rodrigues RM, Serrant L, et al
    Factors associated with hospitalization and death among TB/HIV co-infected persons in Porto Alegre, Brazil.
    PLoS One. 2019;14:e0209174.
    PubMed     Text format     Abstract available


  140. LI Y, Huang H, Dong W, Lan T, et al
    Penetration of linezolid into bone tissue 24 h after administration in patients with multidrug-resistant spinal tuberculosis.
    PLoS One. 2019;14:e0223391.
    PubMed     Text format     Abstract available


  141. NYATHI S, Dlodlo RA, Satyanarayana S, Takarinda KC, et al
    Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe.
    PLoS One. 2019;14:e0223076.
    PubMed     Text format     Abstract available


  142. YEKTAKOOSHALI MH, Movahedzadeh F, Foumani AA, Sabati H, et al
    Is latent tuberculosis infection challenging in Iranian health care workers? A systematic review and meta-analysis.
    PLoS One. 2019;14:e0223335.
    PubMed     Text format     Abstract available


  143. BRAND EM, Rossetto M, Calvo KDS, Winkler GB, et al
    Factors associated with directly observed treatment in tuberculosis/HIV coinfection cases in Porto Alegre, 2009-2013: A retrospective cohort.
    PLoS One. 2019;14:e0222786.
    PubMed     Text format     Abstract available


  144. MILLER AP, Malekinejad M, Horvath H, Blodgett JC, et al
    Healthcare facility-based strategies to improve tuberculosis testing and linkage to care in non-U.S.-born population in the United States: A systematic review.
    PLoS One. 2019;14:e0223077.
    PubMed     Text format     Abstract available



  145. Correction: BCG vaccination and tuberculosis prevention: A forty years cohort study, Monastir, Tunisia.
    PLoS One. 2019;14:e0223903.
    PubMed     Text format     Abstract available


  146. EARLY JV, Mullen S, Parish T
    A rapid, low pH, nutrient stress, assay to determine the bactericidal activity of compounds against non-replicating Mycobacterium tuberculosis.
    PLoS One. 2019;14:e0222970.
    PubMed     Text format     Abstract available


  147. BOUTON TC, de Vos M, Ragan EJ, White LF, et al
    Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa: A retrospective cohort analysis.
    PLoS One. 2019;14:e0223308.
    PubMed     Text format     Abstract available


  148. TAGHIPOUR A, Mosadegh M, Kheirollahzadeh F, Olfatifar M, et al
    Are intestinal helminths playing a positive role in tuberculosis risk? A systematic review and meta-analysis.
    PLoS One. 2019;14:e0223722.
    PubMed     Text format     Abstract available


    January 2018
  149. MACIEL EMGS, Amancio JS, Castro DB, Braga JU, et al
    Social determinants of pulmonary tuberculosis treatment non-adherence in Rio de Janeiro, Brazil.
    PLoS One. 2018;13:e0190578.
    PubMed     Text format     Abstract available


  150. FELEKE BE, Alene GD, Feleke TE, Motebaynore Y, et al
    Clinical response of tuberculosis patients, a prospective cohort study.
    PLoS One. 2018;13:e0190207.
    PubMed     Text format     Abstract available


  151. LI J, Yip BHK, Leung C, Chung W, et al
    Screening for latent and active tuberculosis infection in the elderly at admission to residential care homes: A cost-effectiveness analysis in an intermediate disease burden area.
    PLoS One. 2018;13:e0189531.
    PubMed     Text format     Abstract available


  152. PARLATO S, Chiacchio T, Salerno D, Petrone L, et al
    Impaired IFN-alpha-mediated signal in dendritic cells differentiates active from latent tuberculosis.
    PLoS One. 2018;13:e0189477.
    PubMed     Text format     Abstract available


  153. HARRINGTON-KANDT R, Stylianou E, Eddowes LA, Lim PJ, et al
    Hepcidin deficiency and iron deficiency do not alter tuberculosis susceptibility in a murine M.tb infection model.
    PLoS One. 2018;13:e0191038.
    PubMed     Text format     Abstract available


  154. ABEBE F, Belay M, Legesse M, K L M C F, et al
    IgA and IgG against Mycobacterium tuberculosis Rv2031 discriminate between pulmonary tuberculosis patients, Mycobacterium tuberculosis-infected and non-infected individuals.
    PLoS One. 2018;13:e0190989.
    PubMed     Text format     Abstract available


  155. MCCARTHY K, Fielding K, Churchyard GJ, Grant AD, et al
    Empiric tuberculosis treatment in South African primary health care facilities - for whom, where, when and why: Implications for the development of tuberculosis diagnostic tests.
    PLoS One. 2018;13:e0191608.
    PubMed     Text format     Abstract available


  156. MUPFUMI L, Moyo S, Molebatsi K, Thami PK, et al
    Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.
    PLoS One. 2018;13:e0192030.
    PubMed     Text format     Abstract available


  157. ZHU Z, Hao D, Wang B, Gao W, et al
    Selection of surgical treatment approaches for cervicothoracic spinal tuberculosis: A 10-year case review.
    PLoS One. 2018;13:e0192581.
    PubMed     Text format     Abstract available


  158. VEESA KS, John KR, Moonan PK, Kaliappan SP, et al
    Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India.
    PLoS One. 2018;13:e0191591.
    PubMed     Text format     Abstract available


  159. STOCKDALE L, Nash S, Nalwoga A, Painter H, et al
    Human cytomegalovirus epidemiology and relationship to tuberculosis and cardiovascular disease risk factors in a rural Ugandan cohort.
    PLoS One. 2018;13:e0192086.
    PubMed     Text format     Abstract available


  160. UFIMTSEVA E, Eremeeva N, Petrunina E, Umpeleva T, et al
    Ex vivo expansion of alveolar macrophages with Mycobacterium tuberculosis from the resected lungs of patients with pulmonary tuberculosis.
    PLoS One. 2018;13:e0191918.
    PubMed     Text format     Abstract available


  161. TILAHUN M, Ameni G, Desta K, Zewude A, et al
    Molecular epidemiology and drug sensitivity pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in and around Ambo Town, Central Ethiopia.
    PLoS One. 2018;13:e0193083.
    PubMed     Text format     Abstract available


  162. KORTHALS ALTES H, Kloet S, Cobelens F, Bootsma M, et al
    Latent tuberculosis infection in foreign-born communities: Import vs. transmission in The Netherlands derived through mathematical modelling.
    PLoS One. 2018;13:e0192282.
    PubMed     Text format     Abstract available


  163. GAUTAM SS, Mac Aogain M, Cooley LA, Haug G, et al
    Molecular epidemiology of tuberculosis in Tasmania and genomic characterisation of its first known multi-drug resistant case.
    PLoS One. 2018;13:e0192351.
    PubMed     Text format     Abstract available


  164. TIWARI V, Kedia S, Garg SK, Rampal R, et al
    CD4+ CD25+ FOXP3+ T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn's disease.
    PLoS One. 2018;13:e0193433.
    PubMed     Text format     Abstract available


  165. BISALLAH CI, Rampal L, Lye MS, Mohd Sidik S, et al
    Effectiveness of health education intervention in improving knowledge, attitude, and practices regarding Tuberculosis among HIV patients in General Hospital Minna, Nigeria - A randomized control trial.
    PLoS One. 2018;13:e0192276.
    PubMed     Text format     Abstract available


  166. DUDLEY L, Mukinda F, Dyers R, Marais F, et al
    Mind the gap! Risk factors for poor continuity of care of TB patients discharged from a hospital in the Western Cape, South Africa.
    PLoS One. 2018;13:e0190258.
    PubMed     Text format     Abstract available


  167. BOJOVIC O, Medenica M, Zivkovic D, Rakocevic B, et al
    Factors associated with patient and health system delays in diagnosis and treatment of tuberculosis in Montenegro, 2015-2016.
    PLoS One. 2018;13:e0193997.
    PubMed     Text format     Abstract available


  168. PEREIRA GR, Barbosa MS, Dias NJD, Almeida CPB, et al
    Impact of introduction of Xpert MTB/RIF test on tuberculosis (TB) diagnosis in a city with high TB incidence in Brazil.
    PLoS One. 2018;13:e0193988.
    PubMed     Text format     Abstract available


  169. BASTARD M, Sanchez-Padilla E, du Cros P, Khamraev AK, et al
    Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.
    PLoS One. 2018;13:e0193491.
    PubMed     Text format     Abstract available


  170. RIVIERE J, Le Strat Y, Hendrikx P, Dufour B, et al
    Perceptions and acceptability of some stakeholders about the bovine tuberculosis surveillance system for wildlife (Sylvatub) in France.
    PLoS One. 2018;13:e0194447.
    PubMed     Text format     Abstract available


  171. MUNRO-ROJAS D, Fernandez-Morales E, Zarrabal-Meza J, Martinez-Cazares MT, et al
    Genetic diversity of drug and multidrug-resistant Mycobacterium tuberculosis circulating in Veracruz, Mexico.
    PLoS One. 2018;13:e0193626.
    PubMed     Text format     Abstract available


  172. LA MANNA MP, Orlando V, Li Donni P, Sireci G, et al
    Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.
    PLoS One. 2018;13:e0192664.
    PubMed     Text format     Abstract available


  173. BLANCO-GUILLOT F, Castaneda-Cediel ML, Cruz-Hervert P, Ferreyra-Reyes L, et al
    Genotyping and spatial analysis of pulmonary tuberculosis and diabetes cases in the state of Veracruz, Mexico.
    PLoS One. 2018;13:e0193911.
    PubMed     Text format     Abstract available


  174. DANGISSO MH, Woldesemayat EM, Datiko DG, Lindtjorn B, et al
    Long-term outcome of smear-positive tuberculosis patients after initiation and completion of treatment: A ten-year retrospective cohort study.
    PLoS One. 2018;13:e0193396.
    PubMed     Text format     Abstract available


  175. SEIPONE ID, Singh R, Patel VB, Singh A, et al
    Tuberculous meningitis is associated with higher cerebrospinal HIV-1 viral loads compared to other HIV-1-associated meningitides.
    PLoS One. 2018;13:e0192060.
    PubMed     Text format     Abstract available


  176. WANGARI IM, Stone L
    Backward bifurcation and hysteresis in models of recurrent tuberculosis.
    PLoS One. 2018;13:e0194256.
    PubMed     Text format     Abstract available


  177. ESHETIE S, Gizachew M, Alebel A, van Soolingen D, et al
    Tuberculosis treatment outcomes in Ethiopia from 2003 to 2016, and impact of HIV co-infection and prior drug exposure: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0194675.
    PubMed     Text format     Abstract available


  178. ASHHURST AS, Parumasivam T, Chan JGY, Lin LCW, et al
    PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection.
    PLoS One. 2018;13:e0194620.
    PubMed     Text format     Abstract available


  179. STOCKBRIDGE EL, Miller TL, Carlson EK, Ho C, et al
    Private sector tuberculosis prevention in the US: Characteristics associated with interferon-gamma release assay or tuberculin skin testing.
    PLoS One. 2018;13:e0193432.
    PubMed     Text format     Abstract available


  180. TAKAKI K, Ramakrishnan L, Basu S
    A zebrafish model for ocular tuberculosis.
    PLoS One. 2018;13:e0194982.
    PubMed     Text format     Abstract available


  181. DENNIS EM, Hao Y, Tamambang M, Roshan TN, et al
    Tuberculosis during pregnancy in the United States: Racial/ethnic disparities in pregnancy complications and in-hospital death.
    PLoS One. 2018;13:e0194836.
    PubMed     Text format     Abstract available


  182. NOGUEIRA BMF, Rolla VC, Akrami KM, Kiene SM, et al
    Factors associated with tuberculosis treatment delay in patients co-infected with HIV in a high prevalence area in Brazil.
    PLoS One. 2018;13:e0195409.
    PubMed     Text format     Abstract available


  183. KONIG WALLES J, Tesfaye F, Jansson M, Tolera Balcha T, et al
    Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting.
    PLoS One. 2018;13:e0193589.
    PubMed     Text format     Abstract available


  184. JAJOU R, Neeling A, Hunen RV, Vries G, et al
    Epidemiological links between tuberculosis cases identified twice as efficiently by whole genome sequencing than conventional molecular typing: A population-based study.
    PLoS One. 2018;13:e0195413.
    PubMed     Text format     Abstract available


  185. QUAGLIO G, Pizzol D, Bortolani A, Manenti F, et al
    Breast tuberculosis in men: A systematic review.
    PLoS One. 2018;13:e0194766.
    PubMed     Text format     Abstract available


  186. PARMAR MM, Sachdeva KS, Dewan PK, Rade K, et al
    Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
    PLoS One. 2018;13:e0193903.
    PubMed     Text format     Abstract available


  187. HUDSON M, Rutherford GW, Weiser S, Fair E, et al
    Linking private, for-profit providers to public sector services for HIV and tuberculosis co-infected patients: A systematic review.
    PLoS One. 2018;13:e0194960.
    PubMed     Text format     Abstract available


  188. CHAMIE G, Kato-Maeda M, Emperador DM, Wandera B, et al
    Spatial overlap links seemingly unconnected genotype-matched TB cases in rural Uganda.
    PLoS One. 2018;13:e0192666.
    PubMed     Text format     Abstract available


  189. SHEWADE HD, Kokane AM, Singh AR, Parmar M, et al
    Provider reported barriers and solutions to improve testing among tuberculosis patients 'eligible for drug susceptibility test': A qualitative study from programmatic setting in India.
    PLoS One. 2018;13:e0196162.
    PubMed     Text format     Abstract available


  190. HELLA J, Cercamondi CI, Mhimbira F, Sasamalo M, et al
    Anemia in tuberculosis cases and household controls from Tanzania: Contribution of disease, coinfections, and the role of hepcidin.
    PLoS One. 2018;13:e0195985.
    PubMed     Text format     Abstract available


  191. DANGISSO MH, Woldesemayat EM, Datiko DG, Lindtjorn B, et al
    Correction: Long-term outcome of smear-positive tuberculosis patients after initiation and completion of treatment: A ten-year retrospective cohort study.
    PLoS One. 2018;13:e0196432.
    PubMed     Text format     Abstract available


  192. KIM SJ, Ye S, Ha E, Chun EM, et al
    Association of body mass index with incident tuberculosis in Korea.
    PLoS One. 2018;13:e0195104.
    PubMed     Text format     Abstract available


  193. WU W, Yang M, Xu M, Ding C, et al
    Diagnostic delay and mortality of active tuberculosis in patients after kidney transplantation in a tertiary care hospital in China.
    PLoS One. 2018;13:e0195695.
    PubMed     Text format     Abstract available


  194. LEUNG-THEUNG-LONG S, Coupet CA, Gouanvic M, Schmitt D, et al
    A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis.
    PLoS One. 2018;13:e0196815.
    PubMed     Text format     Abstract available


  195. RENIER W, Bourdin A, Rubbo PA, Peries M, et al
    B cells response directed against Cut4 and CFP21 lipolytic enzymes in active and latent tuberculosis infections.
    PLoS One. 2018;13:e0196470.
    PubMed     Text format     Abstract available


  196. MANANA PN, Kuonza L, Musekiwa A, Koornhof H, et al
    Feasibility of using postal and web-based surveys to estimate the prevalence of tuberculosis among health care workers in South Africa.
    PLoS One. 2018;13:e0197022.
    PubMed     Text format     Abstract available


  197. PIENAAR E, Linderman JJ, Kirschner DE
    Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas.
    PLoS One. 2018;13:e0196322.
    PubMed     Text format     Abstract available


  198. ARRIETA-VILLEGAS C, Peralvarez T, Vidal E, Puighibet Z, et al
    Efficacy of parenteral vaccination against tuberculosis with heat-inactivated Mycobacterium bovis in experimentally challenged goats.
    PLoS One. 2018;13:e0196948.
    PubMed     Text format     Abstract available


  199. JORSTAD MD, Marijani M, Dyrhol-Riise AM, Sviland L, et al
    MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar.
    PLoS One. 2018;13:e0196723.
    PubMed     Text format     Abstract available


  200. PADMASAWITRI TIA, Frederix GW, Alisjahbana B, Klungel O, et al
    Disparities in model-based cost-effectiveness analyses of tuberculosis diagnosis: A systematic review.
    PLoS One. 2018;13:e0193293.
    PubMed     Text format     Abstract available


  201. TSENG YL, Chang CC, Chen YY, Liu YS, et al
    From one incision to one port: The surgical technique and the evolution of segmentectomy in patients with pulmonary tuberculosis.
    PLoS One. 2018;13:e0197283.
    PubMed     Text format     Abstract available


  202. JAJOU R, de Neeling A, van Hunen R, de Vries G, et al
    Correction: Epidemiological links between tuberculosis cases identified twice as efficiently by whole genome sequencing than conventional molecular typing: A population-based study.
    PLoS One. 2018;13:e0197556.
    PubMed     Text format     Abstract available


  203. ORDONEZ AA, Pokkali S, Kim S, Carr B, et al
    Adjunct antibody administration with standard treatment reduces relapse rates in a murine tuberculosis model of necrotic granulomas.
    PLoS One. 2018;13:e0197474.
    PubMed     Text format     Abstract available


  204. ALENE KA, Viney K, Yi H, McBryde ES, et al
    Comparison of the validity of smear and culture conversion as a prognostic marker of treatment outcome in patients with multidrug-resistant tuberculosis.
    PLoS One. 2018;13:e0197880.
    PubMed     Text format     Abstract available


  205. ATALELL KA, Birhan Tebeje N, Ekubagewargies DT
    Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.
    PLoS One. 2018;13:e0197145.
    PubMed     Text format     Abstract available


  206. NAHID P, Jarlsberg LG, Kato-Maeda M, Segal MR, et al
    Interplay of strain and race/ethnicity in the innate immune response to M. tuberculosis.
    PLoS One. 2018;13:e0195392.
    PubMed     Text format     Abstract available


  207. RAIZADA N, Khaparde SD, Salhotra VS, Rao R, et al
    Accelerating access to quality TB care for pediatric TB cases through better diagnostic strategy in four major cities of India.
    PLoS One. 2018;13:e0193194.
    PubMed     Text format     Abstract available


  208. DELLA BELLA C, Spinicci M, Grassi A, Bartalesi F, et al
    Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis.
    PLoS One. 2018;13:e0197825.
    PubMed     Text format     Abstract available


  209. MUPFUMI L, Moyo S, Molebatsi K, Thami PK, et al
    Correction: Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.
    PLoS One. 2018;13:e0198711.
    PubMed     Text format     Abstract available


  210. LI Y, Jia W, Lei G, Zhao D, et al
    Diagnostic efficiency of Xpert MTB/RIF assay for osteoarticular tuberculosis in patients with inflammatory arthritis in China.
    PLoS One. 2018;13:e0198600.
    PubMed     Text format     Abstract available


  211. DEKHIL N, Skhairia MA, Mhenni B, Ben Fradj S, et al
    Automated IS6110-based fingerprinting of Mycobacterium tuberculosis: Reaching unprecedented discriminatory power and versatility.
    PLoS One. 2018;13:e0197913.
    PubMed     Text format     Abstract available


  212. LI L, Cheng Y, Emrich S, Schorey J, et al
    Activation of endothelial cells by extracellular vesicles derived from Mycobacterium tuberculosis infected macrophages or mice.
    PLoS One. 2018;13:e0198337.
    PubMed     Text format     Abstract available


  213. PAPP AC, Azad AK, Pietrzak M, Williams A, et al
    AmpliSeq transcriptome analysis of human alveolar and monocyte-derived macrophages over time in response to Mycobacterium tuberculosis infection.
    PLoS One. 2018;13:e0198221.
    PubMed     Text format     Abstract available


  214. KIGOZI E, Kasule GW, Musisi K, Lukoye D, et al
    Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.
    PLoS One. 2018;13:e0198091.
    PubMed     Text format     Abstract available


  215. KORTHALS ALTES H, Kloet S, Cobelens F, Bootsma M, et al
    Correction: Latent tuberculosis infection in foreign-born communities: Import vs. transmission in The Netherlands derived through mathematical modelling.
    PLoS One. 2018;13:e0198376.
    PubMed     Text format     Abstract available


  216. TADESSE S, Enqueselassie F, Hagos S
    Spatial and space-time clustering of tuberculosis in Gurage Zone, Southern Ethiopia.
    PLoS One. 2018;13:e0198353.
    PubMed     Text format     Abstract available


  217. MESFIN EA, Beyene D, Tesfaye A, Admasu A, et al
    Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
    PLoS One. 2018;13:e0197737.
    PubMed     Text format     Abstract available


  218. ADESOKAN HK, Akinseye VO, Sulaimon MA
    Knowledge and practices about zoonotic tuberculosis prevention and associated determinants amongst livestock workers in Nigeria; 2015.
    PLoS One. 2018;13:e0198810.
    PubMed     Text format     Abstract available



  219. Correction: Association of body mass index with incident tuberculosis in Korea.
    PLoS One. 2018;13:e0199065.
    PubMed     Text format     Abstract available


  220. MCKINLEY TJ, Lipschutz-Powell D, Mitchell AP, Wood JLN, et al
    Risk factors and variations in detection of new bovine tuberculosis breakdowns via slaughterhouse surveillance in Great Britain.
    PLoS One. 2018;13:e0198760.
    PubMed     Text format     Abstract available


  221. BRAHAM CA, White PJ, Arinaminpathy N
    Management of tuberculosis by healthcare practitioners in Pakistan: A systematic review.
    PLoS One. 2018;13:e0199413.
    PubMed     Text format     Abstract available


  222. YIHUNIE AKALU T, Muchie KF, Alemu Gelaye K
    Time to sputum culture conversion and its determinants among Multi-drug resistant Tuberculosis patients at public hospitals of the Amhara Regional State: A multicenter retrospective follow up study.
    PLoS One. 2018;13:e0199320.
    PubMed     Text format     Abstract available


  223. KAWATSU L, Uchimura K, Ohkado A, Kato S, et al
    A combination of quantitative and qualitative methods in investigating risk factors for lost to follow-up for tuberculosis treatment in Japan - Are physicians and nurses at a particular risk?
    PLoS One. 2018;13:e0198075.
    PubMed     Text format     Abstract available


  224. SSENGOOBA W, Nakayita G, Namaganda CC, Joloba ML, et al
    Agreement of Middle brook 7H10 with Lowenstein Jensen and accuracy of the Sensititre MYCOTB plate using either method as a reference standard for Mycobacterium tuberculosis first line drug susceptibility testing.
    PLoS One. 2018;13:e0199638.
    PubMed     Text format     Abstract available


  225. MBU ET, Sauter F, Zoufaly A, Bronsvoort BMC, et al
    Tuberculosis in people newly diagnosed with HIV at a large HIV care and treatment center in Northwest Cameroon: Burden, comparative screening and diagnostic yields, and patient outcomes.
    PLoS One. 2018;13:e0199634.
    PubMed     Text format     Abstract available


  226. YU G, Shen Y, Zhong F, Ye B, et al
    Diagnostic accuracy of the loop-mediated isothermal amplification assay for extrapulmonary tuberculosis: A meta-analysis.
    PLoS One. 2018;13:e0199290.
    PubMed     Text format     Abstract available


  227. SHIBABAW A, Gelaw B, Wang SH, Tessema B, et al
    Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
    PLoS One. 2018;13:e0198080.
    PubMed     Text format     Abstract available


  228. DESTA KT, Masango TE, Nkosi ZZ
    Performance of the National Tuberculosis Control Program in the post conflict Liberia.
    PLoS One. 2018;13:e0199474.
    PubMed     Text format     Abstract available


  229. NAFADE V, Nash M, Huddart S, Pande T, et al
    A bibliometric analysis of tuberculosis research, 2007-2016.
    PLoS One. 2018;13:e0199706.
    PubMed     Text format     Abstract available


  230. WAI PP, Shewade HD, Kyaw NTT, Thein S, et al
    Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar.
    PLoS One. 2018;13:e0194087.
    PubMed     Text format     Abstract available


  231. MCDOWELL A, Raizada N, Khaparde SD, Rao R, et al
    "Before Xpert I only had my expertise": A qualitative study on the utilization and effects of Xpert technology among pediatricians in 4 Indian cities.
    PLoS One. 2018;13:e0193656.
    PubMed     Text format     Abstract available


  232. BOFFA J, Mayan M, Ndlovu S, Mhlaba T, et al
    The role of agency in the implementation of Isoniazid Preventive Therapy (IPT): Lessons from oMakoti in uMgungundlovu District, South Africa.
    PLoS One. 2018;13:e0193571.
    PubMed     Text format     Abstract available


  233. RAIZADA N, Khaparde SD, Swaminathan S, Sarin S, et al
    Catalysing progressive uptake of newer diagnostics by health care providers through outreach and education in four major cities of India.
    PLoS One. 2018;13:e0193341.
    PubMed     Text format     Abstract available


  234. NDLOVU Z, Fajardo E, Mbofana E, Maparo T, et al
    Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe.
    PLoS One. 2018;13:e0193577.
    PubMed     Text format     Abstract available


  235. CERQUEIRA-RODRIGUES B, Mendes A, Correia-Neves M, Nobrega C, et al
    Ag85-focused T-cell immune response controls Mycobacterium avium chronic infection.
    PLoS One. 2018;13:e0193596.
    PubMed     Text format     Abstract available


  236. JEONG DH, Kang J, Jung YJ, Yoo B, et al
    Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA.
    PLoS One. 2018;13:e0198756.
    PubMed     Text format     Abstract available


  237. MARABA N, Hoffmann CJ, Chihota VN, Chang LW, et al
    Using mHealth to improve tuberculosis case identification and treatment initiation in South Africa: Results from a pilot study.
    PLoS One. 2018;13:e0199687.
    PubMed     Text format     Abstract available


  238. PAGE-SHIPP L, Lewis JJ, Velen K, Senoge S, et al
    Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South Africa.
    PLoS One. 2018;13:e0192089.
    PubMed     Text format     Abstract available


  239. VELAYUTHAM B, Chadha VK, Singla N, Narang P, et al
    Recurrence of tuberculosis among newly diagnosed sputum positive pulmonary tuberculosis patients treated under the Revised National Tuberculosis Control Programme, India: A multi-centric prospective study.
    PLoS One. 2018;13:e0200150.
    PubMed     Text format     Abstract available


  240. WILLEMSE D, Weber B, Masino L, Warren RM, et al
    Rv1460, a SufR homologue, is a repressor of the suf operon in Mycobacterium tuberculosis.
    PLoS One. 2018;13:e0200145.
    PubMed     Text format     Abstract available


  241. SILVA DAAD, Silva MVD, Barros CCO, Alexandre PBD, et al
    TNF-alpha blockade impairs in vitro tuberculous granuloma formation and down modulate Th1, Th17 and Treg cytokines.
    PLoS One. 2018;13:e0194430.
    PubMed     Text format     Abstract available


  242. ZHANG R, Xi X, Wang C, Pan Y, et al
    Therapeutic effects of recombinant human interleukin 2 as adjunctive immunotherapy against tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0201025.
    PubMed     Text format     Abstract available


  243. BARUA M, Van Driel F, Jansen W
    Tuberculosis and the sexual and reproductive lives of women in Bangladesh.
    PLoS One. 2018;13:e0201134.
    PubMed     Text format     Abstract available


  244. MEYVISCH P, Kambili C, Andries K, Lounis N, et al
    Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trial.
    PLoS One. 2018;13:e0200539.
    PubMed     Text format     Abstract available


  245. PARRIOTT A, Malekinejad M, Miller AP, Horvath H, et al
    Yield of testing and treatment for tuberculosis among foreign-born persons during contact investigations in the United States: A semi-systematic review.
    PLoS One. 2018;13:e0200485.
    PubMed     Text format     Abstract available


  246. ORLANDO S, Triulzi I, Ciccacci F, Palla I, et al
    Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
    PLoS One. 2018;13:e0200523.
    PubMed     Text format     Abstract available


  247. PANDE T, Huddart S, Xavier W, Kulavalli S, et al
    Prevalence of diabetes mellitus amongst hospitalized tuberculosis patients at an Indian tertiary care center: A descriptive analysis.
    PLoS One. 2018;13:e0200838.
    PubMed     Text format     Abstract available


  248. CHIANG TY, Fan SY, Jou R
    Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting.
    PLoS One. 2018;13:e0200755.
    PubMed     Text format     Abstract available


  249. MEEHAN SA, Sloot R, Draper HR, Naidoo P, et al
    Factors associated with linkage to HIV care and TB treatment at community-based HIV testing services in Cape Town, South Africa.
    PLoS One. 2018;13:e0195208.
    PubMed     Text format     Abstract available


  250. WALKER IF, Khanal S, Hicks JP, Lamichhane B, et al
    Implementation of a psychosocial support package for people receiving treatment for multidrug-resistant tuberculosis in Nepal: A feasibility and acceptability study.
    PLoS One. 2018;13:e0201163.
    PubMed     Text format     Abstract available


  251. GARCIA PJ, Hernandez-Cordova G, Pourjavaheri P, Gomez-Paredes HJ, et al
    Knowledge, attitudes and practices related to tuberculosis in pharmacy workers in a cross-sectional survey in El Agustino, Peru.
    PLoS One. 2018;13:e0196648.
    PubMed     Text format     Abstract available


  252. KOSTER K, Largen A, Foster JT, Drees KP, et al
    Whole genome SNP analysis suggests unique virulence factor differences of the Beijing and Manila families of Mycobacterium tuberculosis found in Hawaii.
    PLoS One. 2018;13:e0201146.
    PubMed     Text format     Abstract available


  253. CHIHOTA VN, Niehaus A, Streicher EM, Wang X, et al
    Geospatial distribution of Mycobacterium tuberculosis genotypes in Africa.
    PLoS One. 2018;13:e0200632.
    PubMed     Text format     Abstract available


  254. DUTTA A, Pattanaik S, Choudhury R, Nanda P, et al
    Impact of involvement of non-formal health providers on TB case notification among migrant slum-dwelling populations in Odisha, India.
    PLoS One. 2018;13:e0196067.
    PubMed     Text format     Abstract available


  255. PATHMANATHAN I, Pasipamire M, Pals S, Dokubo EK, et al
    High uptake of antiretroviral therapy among HIV-positive TB patients receiving co-located services in Swaziland.
    PLoS One. 2018;13:e0196831.
    PubMed     Text format     Abstract available


  256. LOVEDAY M, Wallengren K, Reddy T, Besada D, et al
    MDR-TB patients in KwaZulu-Natal, South Africa: Cost-effectiveness of 5 models of care.
    PLoS One. 2018;13:e0196003.
    PubMed     Text format     Abstract available


  257. NGUYEN DT, Jenkins HE, Graviss EA
    Prognostic score to predict mortality during TB treatment in TB/HIV co-infected patients.
    PLoS One. 2018;13:e0196022.
    PubMed     Text format     Abstract available


  258. MUTTAMBA W, Ssengooba W, Sekibira R, Kirenga B, et al
    Accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the regional referral hospitals in Uganda: Evidence for country wide roll out.
    PLoS One. 2018;13:e0194741.
    PubMed     Text format     Abstract available


  259. JOSHI B, Lestari T, Graham SM, Baral SC, et al
    The implementation of Xpert MTB/RIF assay for diagnosis of tuberculosis in Nepal: A mixed-methods analysis.
    PLoS One. 2018;13:e0201731.
    PubMed     Text format     Abstract available


  260. PRIEDEMAN SKILES M, Curtis SL, Angeles G, Mullen S, et al
    Evaluating the impact of social support services on tuberculosis treatment default in Ukraine.
    PLoS One. 2018;13:e0199513.
    PubMed     Text format     Abstract available


  261. KO Y, Lee HY, Park YB, Hong SJ, et al
    Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis.
    PLoS One. 2018;13:e0201748.
    PubMed     Text format     Abstract available


  262. NOGUEIRA BMF, Rolla VC, Akrami KM, Kiene SM, et al
    Correction: Factors associated with tuberculosis treatment delay in patients co-infected with HIV in a high prevalence area in Brazil.
    PLoS One. 2018;13:e0202292.
    PubMed     Text format     Abstract available


  263. MURADAS TC, Abbadi BL, Villela AD, Macchi FS, et al
    Pre-clinical evaluation of quinoxaline-derived chalcones in tuberculosis.
    PLoS One. 2018;13:e0202568.
    PubMed     Text format     Abstract available


  264. BISOGNIN F, Lombardi G, Lombardo D, Re MC, et al
    Improvement of Mycobacterium tuberculosis detection by Xpert MTB/RIF Ultra: A head-to-head comparison on Xpert-negative samples.
    PLoS One. 2018;13:e0201934.
    PubMed     Text format     Abstract available


  265. PEREA RAZO CA, Rodriguez Hernandez E, Ponce SIR, Milian Suazo F, et al
    Molecular epidemiology of cattle tuberculosis in Mexico through whole-genome sequencing and spoligotyping.
    PLoS One. 2018;13:e0201981.
    PubMed     Text format     Abstract available


  266. ANAND T, Kishore J, Isaakidis P, Gupte HA, et al
    Integrating screening for non-communicable diseases and their risk factors in routine tuberculosis care in Delhi, India: A mixed-methods study.
    PLoS One. 2018;13:e0202256.
    PubMed     Text format     Abstract available


  267. CHINGONZOH R, Manesen MR, Madlavu MJ, Sopiseka N, et al
    Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013.
    PLoS One. 2018;13:e0202469.
    PubMed     Text format     Abstract available


  268. AVONG YK, Jatau B, Gurumnaan R, Danat N, et al
    Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort study.
    PLoS One. 2018;13:e0200810.
    PubMed     Text format     Abstract available


  269. SHARROCK A, Ruthe A, Andrews ESV, Arcus VA, et al
    VapC proteins from Mycobacterium tuberculosis share ribonuclease sequence specificity but differ in regulation and toxicity.
    PLoS One. 2018;13:e0203412.
    PubMed     Text format     Abstract available


  270. HIZA H, Fenner L, Hella J, Kuchaka D, et al
    Boosting effect of IL-7 in interferon gamma release assays to diagnose Mycobacterium tuberculosis infection.
    PLoS One. 2018;13:e0202525.
    PubMed     Text format     Abstract available


  271. SANTOS AP, Correa RDS, Ribeiro-Alves M, Soares da Silva ACO, et al
    Application of Venn's diagram in the diagnosis of pleural tuberculosis using IFN-gamma, IP-10 and adenosine deaminase.
    PLoS One. 2018;13:e0202481.
    PubMed     Text format     Abstract available


  272. KAWATSU L, Uchimura K, Ohkado A
    A situational analysis of latent tuberculosis infection among incarcerated population in Japan.
    PLoS One. 2018;13:e0203815.
    PubMed     Text format     Abstract available


  273. CHANG CH, Hu CC, Chang Y, Hsieh PH, et al
    Two-stage revision arthroplasty for Mycobacterium Tuberculosis periprosthetic joint infection: An outcome analysis.
    PLoS One. 2018;13:e0203585.
    PubMed     Text format     Abstract available


  274. ALIYU G, El-Kamary SS, Abimiku A, Blattner W, et al
    Demography and the dual epidemics of tuberculosis and HIV: Analysis of cross-sectional data from Sub-Saharan Africa.
    PLoS One. 2018;13:e0191387.
    PubMed     Text format     Abstract available


  275. JORSTAD MD, Amus J, Marijani M, Sviland L, et al
    Diagnostic delay in extrapulmonary tuberculosis and impact on patient morbidity: A study from Zanzibar.
    PLoS One. 2018;13:e0203593.
    PubMed     Text format     Abstract available


  276. TEMESSZENTANDRASI-AMBRUS C, Toth S, Verma R, Banhegyi P, et al
    Characterization of new, efficient Mycobacterium tuberculosis topoisomerase-I inhibitors and their interaction with human ABC multidrug transporters.
    PLoS One. 2018;13:e0202749.
    PubMed     Text format     Abstract available


  277. GUEDES L, Jaeger LH, Liryo A, Rodrigues-Carvalho C, et al
    Tuberculosis in post-contact Native Americans of Brazil: Paleopathological and paleogenetic evidence from the Tenetehara-Guajajara.
    PLoS One. 2018;13:e0202394.
    PubMed     Text format     Abstract available


  278. MOHR E, Snyman L, Mbakaz Z, Caldwell J, et al
    "Life continues": Patient, health care and community care workers perspectives on self-administered treatment for rifampicin-resistant tuberculosis in Khayelitsha, South Africa.
    PLoS One. 2018;13:e0203888.
    PubMed     Text format     Abstract available


  279. TOGUN TO, MacLean E, Kampmann B, Pai M, et al
    Biomarkers for diagnosis of childhood tuberculosis: A systematic review.
    PLoS One. 2018;13:e0204029.
    PubMed     Text format     Abstract available


  280. RAHMAN SMM, Maliha UT, Ahmed S, Kabir S, et al
    Evaluation of Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis in stool samples of adults with pulmonary tuberculosis.
    PLoS One. 2018;13:e0203063.
    PubMed     Text format     Abstract available


  281. HUAMAN MA, Henson D, Rondan PL, Ticona E, et al
    Latent tuberculosis infection is associated with increased unstimulated levels of interferon-gamma in Lima, Peru.
    PLoS One. 2018;13:e0202191.
    PubMed     Text format     Abstract available


  282. BHAVANAM S, Rayat GR, Keelan M, Kunimoto D, et al
    Characterization of immune responses of human PBMCs infected with Mycobacterium tuberculosis H37Ra: Impact of donor declared BCG vaccination history on immune responses and M. tuberculosis growth.
    PLoS One. 2018;13:e0203822.
    PubMed     Text format     Abstract available


  283. MADEIRA DE OLIVEIRA S, Altmayer S, Zanon M, Alves Sidney-Filho L, et al
    Predictors of noncompliance to pulmonary tuberculosis treatment: An insight from South America.
    PLoS One. 2018;13:e0202593.
    PubMed     Text format     Abstract available



  284. Retraction: Survival Analysis of Adult Tuberculosis Disease.
    PLoS One. 2018;13:e0204676.
    PubMed     Text format    


  285. PARK Y, Kim SY, Kim JW, Park MS, et al
    Serial testing of healthcare workers for latent tuberculosis infection and long-term follow up for development of active tuberculosis.
    PLoS One. 2018;13:e0204035.
    PubMed     Text format     Abstract available


  286. YAHYAOUI AZAMI H, Ducrotoy MJ, Bouslikhane M, Hattendorf J, et al
    The prevalence of brucellosis and bovine tuberculosis in ruminants in Sidi Kacem Province, Morocco.
    PLoS One. 2018;13:e0203360.
    PubMed     Text format     Abstract available


  287. MEKONNEN A, Merker M, Collins JM, Addise D, et al
    Molecular epidemiology and drug resistance patterns of Mycobacterium tuberculosis complex isolates from university students and the local community in Eastern Ethiopia.
    PLoS One. 2018;13:e0198054.
    PubMed     Text format     Abstract available


  288. MONTGOMERY SA, Young EF, Durham PG, Zulauf KE, et al
    Efficacy of pyrazinoic acid dry powder aerosols in resolving necrotic and non-necrotic granulomas in a guinea pig model of tuberculosis.
    PLoS One. 2018;13:e0204495.
    PubMed     Text format     Abstract available


  289. BARON S, Peleg Y, Grunwald J, Morgenstern D, et al
    Expression of a recombinant, 4'-Phosphopantetheinylated, active M. tuberculosis fatty acid synthase I in E. coli.
    PLoS One. 2018;13:e0204457.
    PubMed     Text format     Abstract available


  290. AGGERBECK H, Ruhwald M, Hoff ST, Borregaard B, et al
    C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: A phase 3 trial.
    PLoS One. 2018;13:e0204554.
    PubMed     Text format     Abstract available


  291. ARYA S, Kumar SK, Nath A, Kapoor P, et al
    Synergy between tuberculin skin test and proliferative T cell responses to PPD or cell-membrane antigens of Mycobacterium tuberculosis for detection of latent TB infection in a high disease-burden setting.
    PLoS One. 2018;13:e0204429.
    PubMed     Text format     Abstract available


  292. MADAN C, Chopra KK, Satyanarayana S, Surie D, et al
    Developing a model to predict unfavourable treatment outcomes in patients with tuberculosis and human immunodeficiency virus co-infection in Delhi, India.
    PLoS One. 2018;13:e0204982.
    PubMed     Text format     Abstract available


  293. KIMUDA SG, Biraro IA, Bagaya BS, Raynes JG, et al
    Characterising antibody avidity in individuals of varied Mycobacterium tuberculosis infection status using surface plasmon resonance.
    PLoS One. 2018;13:e0205102.
    PubMed     Text format     Abstract available


  294. COLLINS JM, Walker DI, Jones DP, Tukvadze N, et al
    High-resolution plasma metabolomics analysis to detect Mycobacterium tuberculosis-associated metabolites that distinguish active pulmonary tuberculosis in humans.
    PLoS One. 2018;13:e0205398.
    PubMed     Text format     Abstract available


  295. VAN DE BERG S, Jansen-Aaldring N, de Vries G, van den Hof S, et al
    Patient support for tuberculosis patients in low-incidence countries: A systematic review.
    PLoS One. 2018;13:e0205433.
    PubMed     Text format     Abstract available


  296. WU K, Koo J, Jiang X, Chen R, et al
    Correction: Improved Control of Tuberculosis and Activation of Macrophages in Mice Lacking Protein Kinase R.
    PLoS One. 2018;13:e0205424.
    PubMed     Text format     Abstract available


  297. VERDECCHIA M, Keus K, Blankley S, Vambe D, et al
    Model of care and risk factors for poor outcomes in patients on multi-drug resistant tuberculosis treatment at two facilities in eSwatini (formerly Swaziland), 2011-2013.
    PLoS One. 2018;13:e0205601.
    PubMed     Text format     Abstract available


  298. BONNETT SA, Dennison D, Files M, Bajpai A, et al
    A class of hydrazones are active against non-replicating Mycobacterium tuberculosis.
    PLoS One. 2018;13:e0198059.
    PubMed     Text format     Abstract available


  299. KIELMANN K, Vidal N, Riekstina V, Krutikov M, et al
    "Treatment is of primary importance, and social assistance is secondary": A qualitative study on the organisation of tuberculosis (TB) care and patients' experience of starting and staying on TB treatment in Riga, Latvia.
    PLoS One. 2018;13:e0203937.
    PubMed     Text format     Abstract available


  300. ROBA AA, Dasa TT, Weldegebreal F, Asfaw A, et al
    Tuberculosis patients are physically challenged and socially isolated: A mixed methods case-control study of Health Related Quality of Life in Eastern Ethiopia.
    PLoS One. 2018;13:e0204697.
    PubMed     Text format     Abstract available


  301. MULUYE AB, Kebamo S, Teklie T, Alemkere G, et al
    Poor treatment outcomes and its determinants among tuberculosis patients in selected health facilities in East Wollega, Western Ethiopia.
    PLoS One. 2018;13:e0206227.
    PubMed     Text format     Abstract available


  302. OHARA Y, Ozeki Y, Tateishi Y, Mashima T, et al
    Significance of a histone-like protein with its native structure for the diagnosis of asymptomatic tuberculosis.
    PLoS One. 2018;13:e0204160.
    PubMed     Text format     Abstract available


  303. FARR K, Ravindran R, Strnad L, Chang E, et al
    Diagnostic performance of blood inflammatory markers for tuberculosis screening in people living with HIV.
    PLoS One. 2018;13:e0206119.
    PubMed     Text format     Abstract available


  304. LA DISTIA NORA R, Sitompul R, Bakker M, Versnel MA, et al
    Type 1 interferon-inducible gene expression in QuantiFERON Gold TB-positive uveitis: A tool to stratify a high versus low risk of active tuberculosis?
    PLoS One. 2018;13:e0206073.
    PubMed     Text format     Abstract available


  305. LEE MC, Chiang CY, Lee CH, Ho CM, et al
    Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria.
    PLoS One. 2018;13:e0205807.
    PubMed     Text format     Abstract available


  306. EJETA E, Beyene G, Balay G, Bonsa Z, et al
    Factors associated with unsuccessful treatment outcome in tuberculosis patients among refugees and their surrounding communities in Gambella Regional State, Ethiopia.
    PLoS One. 2018;13:e0205468.
    PubMed     Text format     Abstract available


  307. ZHAO X, Yuan Y, Lin Y, Zhang T, et al
    Vitamin D status of tuberculosis patients with diabetes mellitus in different economic areas and associated factors in China.
    PLoS One. 2018;13:e0206372.
    PubMed     Text format     Abstract available


  308. PEDERSEN MK, Andersen AB, Folkvardsen DB, Rasmussen EM, et al
    Set-up and validation of mycobacterial interspersed repetitive unit-variable number of tandem repeat (MIRU-VNTR) analysis of Mycobacterium tuberculosis using BioNumerics software.
    PLoS One. 2018;13:e0205336.
    PubMed     Text format     Abstract available


  309. HUDDART S, Bossuroy T, Pons V, Baral S, et al
    Knowledge about tuberculosis and infection prevention behavior: A nine city longitudinal study from India.
    PLoS One. 2018;13:e0206245.
    PubMed     Text format     Abstract available


  310. ACUNA-VILLAORDUNA C, Schmidt-Castellani LG, Marques-Rodrigues P, White LF, et al
    Cough-aerosol cultures of Mycobacterium tuberculosis in the prediction of outcomes after exposure. A household contact study in Brazil.
    PLoS One. 2018;13:e0206384.
    PubMed     Text format     Abstract available


  311. SAGILI KD, Muniyandi M, Nilgiriwala KS, Shringarpure KS, et al
    Cost-effectiveness of GeneXpert and LED-FM for diagnosis of pulmonary tuberculosis: A systematic review.
    PLoS One. 2018;13:e0205233.
    PubMed     Text format     Abstract available


  312. CARTER SP, Robertson A, Palphramand KL, Chambers MA, et al
    Bait uptake by wild badgers and its implications for oral vaccination against tuberculosis.
    PLoS One. 2018;13:e0206136.
    PubMed     Text format     Abstract available


  313. LI T, Du X, Shewade HD, Soe KT, et al
    What happens to migrant tuberculosis patients who are transferred out using a web-based system in China?
    PLoS One. 2018;13:e0206580.
    PubMed     Text format     Abstract available



  314. Correction: Efficacy of pyrazinoic acid dry powder aerosols in resolving necrotic and non-necrotic granulomas in a guinea pig model of tuberculosis.
    PLoS One. 2018;13:e0207257.
    PubMed     Text format     Abstract available


  315. MUBIN N, Pahari S, Owais M, Zubair S, et al
    Mycobacterium tuberculosis host cell interaction: Role of latency associated protein Acr-1 in differential modulation of macrophages.
    PLoS One. 2018;13:e0206459.
    PubMed     Text format     Abstract available


  316. VAN DE WATER BJ, Silva SG, Prvu Bettger J, Humphreys J, et al
    Provision of guideline-based care for drug-resistant tuberculosis in South Africa: Level of concordance between prescribing practices and guidelines.
    PLoS One. 2018;13:e0203749.
    PubMed     Text format     Abstract available


  317. SCOLARICI M, Dekitani K, Chen L, Sokol-Anderson M, et al
    A scoring strategy for progression risk and rates of treatment completion in subjects with latent tuberculosis.
    PLoS One. 2018;13:e0207582.
    PubMed     Text format     Abstract available


  318. GRENZEL ML, Grande AJ, Paniago AMM, Pompilio MA, et al
    Tuberculosis among correctional facility workers: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0207400.
    PubMed     Text format     Abstract available


  319. KATHAMUTHU GR, Moideen K, Banurekha VV, Nair D, et al
    Altered circulating levels of B cell growth factors and their modulation upon anti-tuberculosis treatment in pulmonary tuberculosis and tuberculous lymphadenitis.
    PLoS One. 2018;13:e0207404.
    PubMed     Text format     Abstract available


  320. WANGARI IM, Trauer J, Stone L
    Modelling heterogeneity in host susceptibility to tuberculosis and its effect on public health interventions.
    PLoS One. 2018;13:e0206603.
    PubMed     Text format     Abstract available


  321. BUI LV, Mor Z, Chemtob D, Ha ST, et al
    Use of Geographically Weighted Poisson Regression to examine the effect of distance on Tuberculosis incidence: A case study in Nam Dinh, Vietnam.
    PLoS One. 2018;13:e0207068.
    PubMed     Text format     Abstract available


  322. SARACENI V, Benzaken AS, Pereira GFM, Andrade KB, et al
    Tuberculosis burden on AIDS in Brazil: A study using linked databases.
    PLoS One. 2018;13:e0207859.
    PubMed     Text format     Abstract available


  323. SAUER CM, Sasson D, Paik KE, McCague N, et al
    Feature selection and prediction of treatment failure in tuberculosis.
    PLoS One. 2018;13:e0207491.
    PubMed     Text format     Abstract available



  324. Correction: Rv1460, a SufR homologue, is a repressor of the suf operon in Mycobacterium tuberculosis.
    PLoS One. 2018;13:e0208568.
    PubMed     Text format     Abstract available


  325. MBUTHIA GW, Olungah CO, Ondicho TG
    Health-seeking pathway and factors leading to delays in tuberculosis diagnosis in West Pokot County, Kenya: A grounded theory study.
    PLoS One. 2018;13:e0207995.
    PubMed     Text format     Abstract available


  326. HERMES R, Saragusty J, Moser I, Barth SA, et al
    Differential detection of tuberculous and non-tuberculous mycobacteria by qPCR in lavage fluids of tuberculosis-suspicious white rhinoceros.
    PLoS One. 2018;13:e0207365.
    PubMed     Text format     Abstract available


  327. LEE CU, Chong S, Choi HW, Choi JC, et al
    Quantitative image analysis using chest computed tomography in the evaluation of lymph node involvement in pulmonary sarcoidosis and tuberculosis.
    PLoS One. 2018;13:e0207959.
    PubMed     Text format     Abstract available


  328. ABRAHAM PR, Devalraju KP, Jha V, Valluri VL, et al
    PPE17 (Rv1168c) protein of Mycobacterium tuberculosis detects individuals with latent TB infection.
    PLoS One. 2018;13:e0207787.
    PubMed     Text format     Abstract available


  329. CLOETE R, Kapp E, Joubert J, Christoffels A, et al
    Molecular modelling and simulation studies of the Mycobacterium tuberculosis multidrug efflux pump protein Rv1258c.
    PLoS One. 2018;13:e0207605.
    PubMed     Text format     Abstract available


  330. GASHU Z, Jerene D, Datiko DG, Hiruy N, et al
    Seasonal patterns of tuberculosis case notification in the tropics of Africa: A six-year trend analysis in Ethiopia.
    PLoS One. 2018;13:e0207552.
    PubMed     Text format     Abstract available


  331. MICHELET L, de Cruz K, Karoui C, Tambosco J, et al
    Second line molecular diagnosis for bovine tuberculosis to improve diagnostic schemes.
    PLoS One. 2018;13:e0207614.
    PubMed     Text format     Abstract available


  332. MASIEWICZ P, Brzostek A, Wolanski M, Dziadek J, et al
    Correction: A Novel Role of the PrpR as a Transcription Factor Involved in the Regulation of Methylcitrate Pathway in Mycobacterium tuberculosis.
    PLoS One. 2018;13:e0208565.
    PubMed     Text format     Abstract available


  333. CORNEJO GARCIA JG, Alarcon Guizado VA, Mendoza Ticona A, Alarcon E, et al
    Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014.
    PLoS One. 2018;13:e0206658.
    PubMed     Text format     Abstract available


  334. DIARRA B, Kone M, Togo ACG, Sarro YDS, et al
    Mycobacterium africanum (Lineage 6) shows slower sputum smear conversion on tuberculosis treatment than Mycobacterium tuberculosis (Lineage 4) in Bamako, Mali.
    PLoS One. 2018;13:e0208603.
    PubMed     Text format     Abstract available



  335. Correction: Molecular modelling and simulation studies of the Mycobacterium tuberculosis multidrug efflux pump protein Rv1258c.
    PLoS One. 2018;13:e0209717.
    PubMed     Text format     Abstract available


  336. KIRIRABWA NS, Kimuli D, DeJene S, Nanziri C, et al
    Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda.
    PLoS One. 2018;13:e0208390.
    PubMed     Text format     Abstract available


  337. VO LNQ, Vu TN, Nguyen HT, Truong TT, et al
    Optimizing community screening for tuberculosis: Spatial analysis of localized case finding from door-to-door screening for TB in an urban district of Ho Chi Minh City, Viet Nam.
    PLoS One. 2018;13:e0209290.
    PubMed     Text format     Abstract available


  338. READHEAD A, Chang AH, Ghosh JK, Sorvillo F, et al
    Challenges and solutions to estimating tuberculosis disease incidence by country of birth in Los Angeles County.
    PLoS One. 2018;13:e0209051.
    PubMed     Text format     Abstract available


  339. JHILMEET N, Lowe DM, Riou C, Scriba TJ, et al
    The effect of antiretroviral treatment on selected genes in whole blood from HIV-infected adults sensitised by Mycobacterium tuberculosis.
    PLoS One. 2018;13:e0209516.
    PubMed     Text format     Abstract available


  340. ENOS M, Sitienei J, Ong'ang'o J, Mungai B, et al
    Kenya tuberculosis prevalence survey 2016: Challenges and opportunities of ending TB in Kenya.
    PLoS One. 2018;13:e0209098.
    PubMed     Text format     Abstract available


  341. SLOGOTSKAYA L, Bogorodskaya E, Ivanova D, Sevostyanova T, et al
    Comparative sensitivity of the test with tuberculosis recombinant allergen, containing ESAT6-CFP10 protein, and Mantoux test with 2 TU PPD-L in newly diagnosed tuberculosis children and adolescents in Moscow.
    PLoS One. 2018;13:e0208705.
    PubMed     Text format     Abstract available


  342. MEKONEN A, Ayele Y, Berhan Y, Woldeyohannes D, et al
    Factors which contributed for low quality sputum smears for the detection of acid fast bacilli (AFB) at selected health centers in Ethiopia: A quality control perspective.
    PLoS One. 2018;13:e0198947.
    PubMed     Text format     Abstract available


  343. ZHOU M, Liu S, Li Q, Wang Q, et al
    Drug resistance characteristics of Mycobacterium tuberculosis isolates between 2014 and 2017 in Sichuan, China: A retrospective study.
    PLoS One. 2018;13:e0209902.
    PubMed     Text format     Abstract available


  344. HTUN YM, Khaing TMM, Aung NM, Yin Y, et al
    Delay in treatment initiation and treatment outcomes among adult patients with multidrug-resistant tuberculosis at Yangon Regional Tuberculosis Centre, Myanmar: A retrospective study.
    PLoS One. 2018;13:e0209932.
    PubMed     Text format     Abstract available


  345. METCALF T, Soria J, Montano SM, Ticona E, et al
    Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis.
    PLoS One. 2018;13:e0198695.
    PubMed     Text format     Abstract available


  346. THAKORE N, Norville R, Franke M, Calderon R, et al
    Automated TruTip nucleic acid extraction and purification from raw sputum.
    PLoS One. 2018;13:e0199869.
    PubMed     Text format     Abstract available


  347. THAKUR A, Andrea A, Mikkelsen H, Woodworth JS, et al
    Targeting the Mincle and TLR3 receptor using the dual agonist cationic adjuvant formulation 9 (CAF09) induces humoral and polyfunctional memory T cell responses in calves.
    PLoS One. 2018;13:e0201253.
    PubMed     Text format     Abstract available


  348. CHANDRASEKARAN P, Mave V, Thiruvengadam K, Gupte N, et al
    Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting.
    PLoS One. 2018;13:e0199360.
    PubMed     Text format     Abstract available


  349. RAIZADA N, Khaparde SD, Rao R, Kalra A, et al
    Upfront Xpert MTB/RIF testing on various specimen types for presumptive infant TB cases for early and appropriate treatment initiation.
    PLoS One. 2018;13:e0202085.
    PubMed     Text format     Abstract available


  350. FAN X, Li N, Wang X, Zhang J, et al
    Protective immune mechanisms of Yifei Tongluo, a Chinese herb formulation, in the treatment of mycobacterial infection.
    PLoS One. 2018;13:e0203678.
    PubMed     Text format     Abstract available


  351. MBOERA LEG, Rumisha SF, Lyimo EP, Chiduo MG, et al
    Cause-specific mortality patterns among hospital deaths in Tanzania, 2006-2015.
    PLoS One. 2018;13:e0205833.
    PubMed     Text format     Abstract available


  352. HIRASEN K, Berhanu R, Evans D, Rosen S, et al
    High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa.
    PLoS One. 2018;13:e0205463.
    PubMed     Text format     Abstract available


  353. PAVAN TAFFNER BM, Mattos FB, Cunha MCD, Saraiva FP, et al
    The use of optical coherence tomography for the detection of ocular toxicity by ethambutol.
    PLoS One. 2018;13:e0204655.
    PubMed     Text format     Abstract available


  354. MUKHTAR F, Butt ZA
    Risk of adverse treatment outcomes among new pulmonary TB patients co-infected with diabetes in Pakistan: A prospective cohort study.
    PLoS One. 2018;13:e0207148.
    PubMed     Text format     Abstract available


  355. TESFAYE B, Alebel A, Gebrie A, Zegeye A, et al
    The twin epidemics: Prevalence of TB/HIV co-infection and its associated factors in Ethiopia; A systematic review and meta-analysis.
    PLoS One. 2018;13:e0203986.
    PubMed     Text format     Abstract available


    January 2017
  356. TORNACK J, Reece ST, Bauer WM, Vogelzang A, et al
    Human and Mouse Hematopoietic Stem Cells Are a Depot for Dormant Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0169119.
    PubMed     Text format     Abstract available


  357. LAI HH, Lai YJ, Yen YF
    Association of Body Mass Index with Timing of Death during Tuberculosis Treatment.
    PLoS One. 2017;12:e0170104.
    PubMed     Text format     Abstract available


  358. SARIKO M, Anderson C, Mujaga BS, Gratz J, et al
    Evaluation of the Antibody in Lymphocyte Supernatant Assay to Detect Active Tuberculosis.
    PLoS One. 2017;12:e0169118.
    PubMed     Text format     Abstract available


  359. PANDEY P, Pant ND, Rijal KR, Shrestha B, et al
    Diagnostic Accuracy of GeneXpert MTB/RIF Assay in Comparison to Conventional Drug Susceptibility Testing Method for the Diagnosis of Multidrug-Resistant Tuberculosis.
    PLoS One. 2017;12:e0169798.
    PubMed     Text format     Abstract available


  360. XIA H, Zheng Y, Zhao B, van den Hof S, et al
    Assessment of a 96-Well Plate Assay of Quantitative Drug Susceptibility Testing for Mycobacterium Tuberculosis Complex in China.
    PLoS One. 2017;12:e0169413.
    PubMed     Text format     Abstract available


  361. SERRANO M, Elguezabal N, Sevilla IA, Geijo MV, et al
    Tuberculosis Detection in Paratuberculosis Vaccinated Calves: New Alternatives against Interference.
    PLoS One. 2017;12:e0169735.
    PubMed     Text format     Abstract available


  362. MWANSA-KAMBAFWILE J, Maitshotlo B, Black A
    Microbiologically Confirmed Tuberculosis: Factors Associated with Pre-Treatment Loss to Follow-Up, and Time to Treatment Initiation.
    PLoS One. 2017;12:e0168659.
    PubMed     Text format     Abstract available


  363. SHARMA SK, Vashishtha R, Chauhan LS, Sreenivas V, et al
    Comparison of TST and IGRA in Diagnosis of Latent Tuberculosis Infection in a High TB-Burden Setting.
    PLoS One. 2017;12:e0169539.
    PubMed     Text format     Abstract available


  364. KHARE G, Nangpal P, Tyagi AK
    Differential Roles of Iron Storage Proteins in Maintaining the Iron Homeostasis in Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0169545.
    PubMed     Text format     Abstract available


  365. ANDRE E, Lufungulo Bahati Y, Mulume Musafiri E, Bahati Rusumba O, et al
    Prediction of Under-Detection of Paediatric Tuberculosis in the Democratic Republic of Congo: Experience of Six Years in the South-Kivu Province.
    PLoS One. 2017;12:e0169014.
    PubMed     Text format     Abstract available


  366. KHANAL S, Elsey H, King R, Baral SC, et al
    Development of a Patient-Centred, Psychosocial Support Intervention for Multi-Drug-Resistant Tuberculosis (MDR-TB) Care in Nepal.
    PLoS One. 2017;12:e0167559.
    PubMed     Text format     Abstract available


  367. LOPEZ-VARELA E, L Garcia-Basteiro A, Augusto OJ, Fraile O, et al
    High Rates of Non-Tuberculous Mycobacteria Isolation in Mozambican Children with Presumptive Tuberculosis.
    PLoS One. 2017;12:e0169757.
    PubMed     Text format     Abstract available


  368. CHEN MY, Lo YC, Chen WC, Wang KF, et al
    Recurrence after Successful Treatment of Multidrug-Resistant Tuberculosis in Taiwan.
    PLoS One. 2017;12:e0170980.
    PubMed     Text format     Abstract available


  369. FU Y, Xu X, Xue J, Duan W, et al
    Deregulated lncRNAs in B Cells from Patients with Active Tuberculosis.
    PLoS One. 2017;12:e0170712.
    PubMed     Text format     Abstract available


  370. GORMLEY E, Ni Bhuachalla D, O'Keeffe J, Murphy D, et al
    Oral Vaccination of Free-Living Badgers (Meles meles) with Bacille Calmette Guerin (BCG) Vaccine Confers Protection against Tuberculosis.
    PLoS One. 2017;12:e0168851.
    PubMed     Text format     Abstract available


  371. SUN Y, Harley D, Vally H, Sleigh A, et al
    Impact of Multidrug Resistance on Tuberculosis Recurrence and Long-Term Outcome in China.
    PLoS One. 2017;12:e0168865.
    PubMed     Text format     Abstract available


  372. HUHNS M, Erbersdobler A, Obliers A, Ropenack P, et al
    Identification of HPV Types and Mycobacterium Tuberculosis Complex in Historical Long-Term Preserved Formalin Fixed Tissues in Different Human Organs.
    PLoS One. 2017;12:e0170353.
    PubMed     Text format     Abstract available


  373. XU Z, Xiao T, Li Y, Yang K, et al
    Reasons for Non-Enrollment in Treatment among Multi-Drug Resistant Tuberculosis Patients in Hunan Province, China.
    PLoS One. 2017;12:e0170718.
    PubMed     Text format     Abstract available


  374. MORISHITA F, Garfin AM, Lew W, Oh KH, et al
    Bringing state-of-the-art diagnostics to vulnerable populations: The use of a mobile screening unit in active case finding for tuberculosis in Palawan, the Philippines.
    PLoS One. 2017;12:e0171310.
    PubMed     Text format     Abstract available


  375. ZHANG Z, Ordonez AA, Smith-Jones P, Wang H, et al
    The biodistribution of 5-[18F]fluoropyrazinamide in Mycobacterium tuberculosis-infected mice determined by positron emission tomography.
    PLoS One. 2017;12:e0170871.
    PubMed     Text format     Abstract available


  376. EBERS A, Stroup S, Mpagama S, Kisonga R, et al
    Determination of plasma concentrations of levofloxacin by high performance liquid chromatography for use at a multidrug-resistant tuberculosis hospital in Tanzania.
    PLoS One. 2017;12:e0170663.
    PubMed     Text format     Abstract available


  377. MACHOVA I, Hubalek M, Lepsik M, Bednarova L, et al
    The Role of Cysteine Residues in Catalysis of Phosphoenolpyruvate Carboxykinase from Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0170373.
    PubMed     Text format     Abstract available


  378. ALENE KA, Viney K, McBryde ES, Clements AC, et al
    Spatial patterns of multidrug resistant tuberculosis and relationships to socio-economic, demographic and household factors in northwest Ethiopia.
    PLoS One. 2017;12:e0171800.
    PubMed     Text format     Abstract available


  379. REYNAUD Y, Zheng C, Wu G, Sun Q, et al
    Bayesian population structure analysis reveals presence of phylogeographically specific sublineages within previously ill-defined T group of Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0171584.
    PubMed     Text format     Abstract available


  380. HUNDIE GB, Woldemeskel D, Gessesse A
    Correction: Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0171964.
    PubMed     Text format     Abstract available


  381. LA MANNA MP, Orlando V, Dieli F, Di Carlo P, et al
    Quantitative and qualitative profiles of circulating monocytes may help identifying tuberculosis infection and disease stages.
    PLoS One. 2017;12:e0171358.
    PubMed     Text format     Abstract available


  382. NAIDOO P, Dunbar R, Caldwell J, Lombard C, et al
    Has universal screening with Xpert(R) MTB/RIF increased the proportion of multidrug-resistant tuberculosis cases diagnosed in a routine operational setting?
    PLoS One. 2017;12:e0172143.
    PubMed     Text format     Abstract available


  383. VLUGGEN C, Soetaert K, Groenen G, Wanlin M, et al
    Molecular epidemiology of Mycobacterium tuberculosis complex in Brussels, 2010-2013.
    PLoS One. 2017;12:e0172554.
    PubMed     Text format     Abstract available


  384. GHIELMETTI G, Scherrer S, Friedel U, Frei D, et al
    Epidemiological tracing of bovine tuberculosis in Switzerland, multilocus variable number of tandem repeat analysis of Mycobacterium bovis and Mycobacterium caprae.
    PLoS One. 2017;12:e0172474.
    PubMed     Text format     Abstract available


  385. MARIN D, Marin N, Del Corral H, Lopez L, et al
    PPD-induced monocyte mitochondrial damage is associated with a protective effect to develop tuberculosis in BCG vaccinated individuals: A cohort study.
    PLoS One. 2017;12:e0171930.
    PubMed     Text format     Abstract available


  386. NABETA P, Havumaki J, Ha DT, Caceres T, et al
    Feasibility of the TBDx automated digital microscopy system for the diagnosis of pulmonary tuberculosis.
    PLoS One. 2017;12:e0173092.
    PubMed     Text format     Abstract available


  387. HERMOSILLA S, You P, Aifah A, Abildayev T, et al
    Identifying risk factors associated with smear positivity of pulmonary tuberculosis in Kazakhstan.
    PLoS One. 2017;12:e0172942.
    PubMed     Text format     Abstract available


  388. JIANG TT, Shi LY, Wei LL, Li X, et al
    Serum amyloid A, protein Z, and C4b-binding protein beta chain as new potential biomarkers for pulmonary tuberculosis.
    PLoS One. 2017;12:e0173304.
    PubMed     Text format     Abstract available


  389. LEE HJ, Lee DG, Choi SM, Park SH, et al
    The demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: High incidence compared with general population.
    PLoS One. 2017;12:e0173250.
    PubMed     Text format     Abstract available


  390. KENDALL EA, Azman AS, Cobelens FG, Dowdy DW, et al
    MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis.
    PLoS One. 2017;12:e0172748.
    PubMed     Text format     Abstract available


  391. SHARPE SA, White AD, Sibley L, Gleeson F, et al
    An aerosol challenge model of tuberculosis in Mauritian cynomolgus macaques.
    PLoS One. 2017;12:e0171906.
    PubMed     Text format     Abstract available


  392. OJO OB, Lougue S, Woldegerima WA
    Bayesian generalized linear mixed modeling of Tuberculosis using informative priors.
    PLoS One. 2017;12:e0172580.
    PubMed     Text format     Abstract available


  393. CLAASSENS MM, van Schalkwyk C, Floyd S, Ayles H, et al
    Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys.
    PLoS One. 2017;12:e0172881.
    PubMed     Text format     Abstract available


  394. ALMEIDA FM, Ventura TL, Amaral EP, Ribeiro SC, et al
    Hypervirulent Mycobacterium tuberculosis strain triggers necrotic lung pathology associated with enhanced recruitment of neutrophils in resistant C57BL/6 mice.
    PLoS One. 2017;12:e0173715.
    PubMed     Text format     Abstract available


  395. SHARMA S, Ryndak MB, Aggarwal AN, Yadav R, et al
    Transcriptome analysis of mycobacteria in sputum samples of pulmonary tuberculosis patients.
    PLoS One. 2017;12:e0173508.
    PubMed     Text format     Abstract available


  396. PATHMANATHAN I, Dokubo EK, Shiraishi RW, Agolory SG, et al
    Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004-2012.
    PLoS One. 2017;12:e0173309.
    PubMed     Text format     Abstract available


  397. DROZNIN M, Johnson A, Johnson AM
    Multidrug resistant tuberculosis in prisons located in former Soviet countries: A systematic review.
    PLoS One. 2017;12:e0174373.
    PubMed     Text format     Abstract available


  398. KARAT AS, Tlali M, Fielding KL, Charalambous S, et al
    Measuring mortality due to HIV-associated tuberculosis among adults in South Africa: Comparing verbal autopsy, minimally-invasive autopsy, and research data.
    PLoS One. 2017;12:e0174097.
    PubMed     Text format     Abstract available


  399. ZHOU Y, van den Hof S, Wang S, Pang Y, et al
    Association between genotype and drug resistance profiles of Mycobacterium tuberculosis strains circulating in China in a national drug resistance survey.
    PLoS One. 2017;12:e0174197.
    PubMed     Text format     Abstract available


  400. FAN L, Shen H, Huang H, Yang R, et al
    Impairment of Wnt/beta-catenin signaling in blood cells of patients with severe cavitary pulmonary tuberculosis.
    PLoS One. 2017;12:e0172549.
    PubMed     Text format     Abstract available


  401. MOORES A, Riesco AB, Schwenk S, Arnvig KB, et al
    Expression, maturation and turnover of DrrS, an unusually stable, DosR regulated small RNA in Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0174079.
    PubMed     Text format     Abstract available


  402. VIDYARTHI A, Khan N, Agnihotri T, Siddiqui KF, et al
    Antibody response against PhoP efficiently discriminates among healthy individuals, tuberculosis patients and their contacts.
    PLoS One. 2017;12:e0173769.
    PubMed     Text format     Abstract available


  403. ADANE K, Spigt M, Johanna L, Noortje D, et al
    Tuberculosis knowledge, attitudes, and practices among northern Ethiopian prisoners: Implications for TB control efforts.
    PLoS One. 2017;12:e0174692.
    PubMed     Text format     Abstract available


  404. CUI Z, Lin M, Nie S, Lan R, et al
    Risk factors associated with Tuberculosis (TB) among people living with HIV/AIDS: A pair-matched case-control study in Guangxi, China.
    PLoS One. 2017;12:e0173976.
    PubMed     Text format     Abstract available


  405. HONG EP, Go MJ, Kim HL, Park JW, et al
    Risk prediction of pulmonary tuberculosis using genetic and conventional risk factors in adult Korean population.
    PLoS One. 2017;12:e0174642.
    PubMed     Text format     Abstract available


  406. KIM C, Park SH, Oh SY, Kim SS, et al
    Comparison of chest CT findings in nontuberculous mycobacterial diseases vs. Mycobacterium tuberculosis lung disease in HIV-negative patients with cavities.
    PLoS One. 2017;12:e0174240.
    PubMed     Text format     Abstract available


  407. HAVUMAKI J, Hillemann D, Ismail N, Omar SV, et al
    Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority study.
    PLoS One. 2017;12:e0173804.
    PubMed     Text format     Abstract available


  408. LOPEZ-VARELA E, Garcia-Basteiro AL, Augusto OJ, Fraile O, et al
    Correction: High Rates of Non-Tuberculous Mycobacteria Isolation in Mozambican Children with Presumptive Tuberculosis.
    PLoS One. 2017;12:e0175613.
    PubMed     Text format     Abstract available


  409. MIRANDA P, Gil-Santana L, Oliveira MG, Mesquita ED, et al
    Sustained elevated levels of C-reactive protein and ferritin in pulmonary tuberculosis patients remaining culture positive upon treatment initiation.
    PLoS One. 2017;12:e0175278.
    PubMed     Text format     Abstract available


  410. ZHANG H, Xin H, Li X, Li H, et al
    A dose-response relationship of smoking with tuberculosis infection: A cross-sectional study among 21008 rural residents in China.
    PLoS One. 2017;12:e0175183.
    PubMed     Text format     Abstract available


  411. ALMEIDA FM, Ventura TL, Amaral EP, Ribeiro SC, et al
    Correction: Hypervirulent Mycobacterium tuberculosis strain triggers necrotic lung pathology associated with enhanced recruitment of neutrophils in resistant C57BL/6 mice.
    PLoS One. 2017;12:e0175652.
    PubMed     Text format     Abstract available


  412. KE CC, Lin CS, Yeh CC, Chung CL, et al
    Correction: Adverse Outcomes after Non-Chest Surgeries in Patients with Pulmonary Tuberculosis: A Nationwide Study.
    PLoS One. 2017;12:e0175603.
    PubMed     Text format     Abstract available


  413. UREN C, Henn BM, Franke A, Wittig M, et al
    A post-GWAS analysis of predicted regulatory variants and tuberculosis susceptibility.
    PLoS One. 2017;12:e0174738.
    PubMed     Text format     Abstract available


  414. KHALIQ A, Ravindran R, Hussainy SF, Krishnan VV, et al
    Field evaluation of a blood based test for active tuberculosis in endemic settings.
    PLoS One. 2017;12:e0173359.
    PubMed     Text format     Abstract available


  415. GAO Y, Ou Y, Deng Q, He B, et al
    Comparison between titanium mesh and autogenous iliac bone graft to restore vertebral height through posterior approach for the treatment of thoracic and lumbar spinal tuberculosis.
    PLoS One. 2017;12:e0175567.
    PubMed     Text format     Abstract available


  416. BALCELLS ME, Garcia P, Tiznado C, Villarroel L, et al
    Association of vitamin D deficiency, season of the year, and latent tuberculosis infection among household contacts.
    PLoS One. 2017;12:e0175400.
    PubMed     Text format     Abstract available


  417. PARDESHI P, Rao KK, Balaji PV
    Rv3634c from Mycobacterium tuberculosis H37Rv encodes an enzyme with UDP-Gal/Glc and UDP-GalNAc 4-epimerase activities.
    PLoS One. 2017;12:e0175193.
    PubMed     Text format     Abstract available


  418. SHAH J, Weltman H, Narciso P, Murphy C, et al
    Dual color fluorescence in situ hybridization (FISH) assays for detecting Mycobacterium tuberculosis and Mycobacterium avium complexes and related pathogens in cultures.
    PLoS One. 2017;12:e0174989.
    PubMed     Text format     Abstract available


  419. WAN X, Koster K, Qian L, Desmond E, et al
    Genomic analyses of the ancestral Manila family of Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0175330.
    PubMed     Text format     Abstract available


  420. LEE SW, Liu CW, Hu JY, Chiang LM, et al
    Suppressors of cytokine signaling in tuberculosis.
    PLoS One. 2017;12:e0176377.
    PubMed     Text format     Abstract available


  421. LOMBARDI G, Di Gregori V, Girometti N, Tadolini M, et al
    Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF.
    PLoS One. 2017;12:e0176186.
    PubMed     Text format     Abstract available


  422. WORKNEH MH, Bjune GA, Yimer SA
    Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review.
    PLoS One. 2017;12:e0175925.
    PubMed     Text format     Abstract available


  423. DEJENE SW, Heitkonig IMA, Prins HHT, Lemma FA, et al
    Correction: Risk Factors for Bovine Tuberculosis (bTB) in Cattle in Ethiopia.
    PLoS One. 2017;12:e0176654.
    PubMed     Text format     Abstract available


  424. KASTIEN-HILKA T, Rosenkranz B, Sinanovic E, Bennett B, et al
    Health-related quality of life in South African patients with pulmonary tuberculosis.
    PLoS One. 2017;12:e0174605.
    PubMed     Text format     Abstract available


  425. NHAVOTO JA, Gronlund A, Klein GO
    Mobile health treatment support intervention for HIV and tuberculosis in Mozambique: Perspectives of patients and healthcare workers.
    PLoS One. 2017;12:e0176051.
    PubMed     Text format     Abstract available


  426. PELISSARI DM, Diaz-Quijano FA
    Household crowding as a potential mediator of socioeconomic determinants of tuberculosis incidence in Brazil.
    PLoS One. 2017;12:e0176116.
    PubMed     Text format     Abstract available


  427. SESHADRI C, Sedaghat N, Campo M, Peterson G, et al
    Transcriptional networks are associated with resistance to Mycobacterium tuberculosis infection.
    PLoS One. 2017;12:e0175844.
    PubMed     Text format     Abstract available


  428. KUMAR NP, Banurekha VV, Nair D, Babu S, et al
    Diminished plasma levels of common gamma-chain cytokines in pulmonary tuberculosis and reversal following treatment.
    PLoS One. 2017;12:e0176495.
    PubMed     Text format     Abstract available


  429. JEONG H, Baek SY, Kim SW, Eun YH, et al
    Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey.
    PLoS One. 2017;12:e0176260.
    PubMed     Text format     Abstract available


  430. PANZER S, Wittig H, Zesch S, Rosendahl W, et al
    Evidence of neurofibromatosis type 1 in a multi-morbid Inca child mummy: A paleoradiological investigation using computed tomography.
    PLoS One. 2017;12:e0175000.
    PubMed     Text format     Abstract available


  431. GADOEV J, Asadov D, Harries AD, Parpieva N, et al
    Recurrent tuberculosis and associated factors: A five - year countrywide study in Uzbekistan.
    PLoS One. 2017;12:e0176473.
    PubMed     Text format     Abstract available


  432. FERRIAN S, Manca C, Lubbe S, Conradie F, et al
    A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis.
    PLoS One. 2017;12:e0176660.
    PubMed     Text format     Abstract available


  433. VON REYN CF, Lahey T, Arbeit RD, Landry B, et al
    Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901.
    PLoS One. 2017;12:e0175215.
    PubMed     Text format     Abstract available


  434. LEMPP JM, Zajdowicz MJ, Hankinson AL, Toney SR, et al
    Assessment of the QuantiFERON-TB Gold In-Tube test for the detection of Mycobacterium tuberculosis infection in United States Navy recruits.
    PLoS One. 2017;12:e0177752.
    PubMed     Text format     Abstract available


  435. OPERARIO DJ, Koeppel AF, Turner SD, Bao Y, et al
    Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis.
    PLoS One. 2017;12:e0176522.
    PubMed     Text format     Abstract available


  436. CHOI SR, Britigan BE, Moran DM, Narayanasamy P, et al
    Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages.
    PLoS One. 2017;12:e0177987.
    PubMed     Text format     Abstract available


  437. MOHR E, Daniels J, Beko B, Isaakidis P, et al
    DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting.
    PLoS One. 2017;12:e0178054.
    PubMed     Text format     Abstract available


  438. ABAYE GE, Abebe T, Worku A, Tolessa D, et al
    Detection of Mycobacterium tuberculosis from the stool of HIV sero-positive individuals suspected of pulmonary tuberculosis.
    PLoS One. 2017;12:e0177529.
    PubMed     Text format     Abstract available


  439. ZHANG L, Cheng X, Bian S, Song Y, et al
    Utility of Th1-cell immune responses for distinguishing active tuberculosis from non-active tuberculosis: A case-control study.
    PLoS One. 2017;12:e0177850.
    PubMed     Text format     Abstract available


  440. XIAO Y, Yu S, Xue Q, Lang S, et al
    A scoring system to effectively evaluate central nervous system tuberculosis in patients with military tuberculosis.
    PLoS One. 2017;12:e0176651.
    PubMed     Text format     Abstract available


  441. MICHELSEN SW, Soborg B, Diaz LJ, Hoff ST, et al
    The dynamics of immune responses to Mycobacterium tuberculosis during different stages of natural infection: A longitudinal study among Greenlanders.
    PLoS One. 2017;12:e0177906.
    PubMed     Text format     Abstract available


  442. LIM CH, Chen HH, Chen YH, Chen DY, et al
    The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan.
    PLoS One. 2017;12:e0178035.
    PubMed     Text format     Abstract available


  443. QADER G, Hamim A, Sayedi M, Rashidi M, et al
    Addressing tuberculosis control in fragile states: Urban DOTS experience in Kabul, Afghanistan, 2009-2015.
    PLoS One. 2017;12:e0178053.
    PubMed     Text format     Abstract available


  444. KUMAR NP, Moideen K, Dolla C, Kumaran P, et al
    Prediabetes is associated with the modulation of antigen-specific Th1/Tc1 and Th17/Tc17 responses in latent Mycobacterium tuberculosis infection.
    PLoS One. 2017;12:e0178000.
    PubMed     Text format     Abstract available


  445. NENASHEVA T, Nikolaev A, Diykanov D, Sukhanova A, et al
    The introduction of mesenchymal stromal cells induces different immunological responses in the lungs of healthy and M. tuberculosis infected mice.
    PLoS One. 2017;12:e0178983.
    PubMed     Text format     Abstract available


  446. LI D, He W, Chen B, Lv P, et al
    Primary multidrug-resistant tuberculosis versus drug-sensitive tuberculosis in non-HIV-infected patients: Comparisons of CT findings.
    PLoS One. 2017;12:e0176354.
    PubMed     Text format     Abstract available


  447. USTERO PA, Kay AW, Ngo K, Golin R, et al
    School and household tuberculosis contact investigations in Swaziland: Active TB case finding in a high HIV/TB burden setting.
    PLoS One. 2017;12:e0178873.
    PubMed     Text format     Abstract available


  448. KHAN MS, Hutchison C, Coker RJ
    Risk factors that may be driving the emergence of drug resistance in tuberculosis patients treated in Yangon, Myanmar.
    PLoS One. 2017;12:e0177999.
    PubMed     Text format     Abstract available


  449. PUCKEN VB, Knubben-Schweizer G, Dopfer D, Groll A, et al
    Evaluating diagnostic tests for bovine tuberculosis in the southern part of Germany: A latent class analysis.
    PLoS One. 2017;12:e0179847.
    PubMed     Text format     Abstract available


  450. WANG L, Li R, Xu C, Zhang H, et al
    The Global Fund in China: Multidrug-resistant tuberculosis nationwide programmatic scale-up and challenges to transition to full country ownership.
    PLoS One. 2017;12:e0177536.
    PubMed     Text format     Abstract available


  451. HUANG LK, Wang HH, Lai YC, Chang SC, et al
    The impact of glycemic status on radiological manifestations of pulmonary tuberculosis in diabetic patients.
    PLoS One. 2017;12:e0179750.
    PubMed     Text format     Abstract available


  452. JIAO W, Blackmore NJ, Nazmi AR, Parker EJ, et al
    Quaternary structure is an essential component that contributes to the sophisticated allosteric regulation mechanism in a key enzyme from Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0180052.
    PubMed     Text format     Abstract available


  453. KAR R, Nangpal P, Mathur S, Singh S, et al
    bioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs.
    PLoS One. 2017;12:e0179513.
    PubMed     Text format     Abstract available


  454. ABRAHAM PR, Pathak N, Pradhan G, Sumanlatha G, et al
    The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients.
    PLoS One. 2017;12:e0179965.
    PubMed     Text format     Abstract available


  455. DUNCAN C, Jamieson FB, Troudt J, Izzo L, et al
    Whole transcriptomic and proteomic analyses of an isogenic M. tuberculosis clinical strain with a naturally occurring 15 Kb genomic deletion.
    PLoS One. 2017;12:e0179996.
    PubMed     Text format     Abstract available


  456. MEYER AJ, Atuheire C, Worodria W, Kizito S, et al
    Sputum quality and diagnostic performance of GeneXpert MTB/RIF among smear-negative adults with presumed tuberculosis in Uganda.
    PLoS One. 2017;12:e0180572.
    PubMed     Text format     Abstract available


  457. OPERARIO DJ, Koeppel AF, Turner SD, Bao Y, et al
    Correction: Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis.
    PLoS One. 2017;12:e0181284.
    PubMed     Text format     Abstract available


  458. BALSEIRO A, Altuzarra R, Vidal E, Moll X, et al
    Assessment of BCG and inactivated Mycobacterium bovis vaccines in an experimental tuberculosis infection model in sheep.
    PLoS One. 2017;12:e0180546.
    PubMed     Text format     Abstract available


  459. WUBULI A, Li Y, Xue F, Yao X, et al
    Seasonality of active tuberculosis notification from 2005 to 2014 in Xinjiang, China.
    PLoS One. 2017;12:e0180226.
    PubMed     Text format     Abstract available


  460. LI S, Liu B, Peng M, Chen M, et al
    Diagnostic accuracy of Xpert MTB/RIF for tuberculosis detection in different regions with different endemic burden: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0180725.
    PubMed     Text format     Abstract available


  461. IDH J, Andersson B, Lerm M, Raffetseder J, et al
    Reduced susceptibility of clinical strains of Mycobacterium tuberculosis to reactive nitrogen species promotes survival in activated macrophages.
    PLoS One. 2017;12:e0181221.
    PubMed     Text format     Abstract available


  462. ONYEDUM CC, Alobu I, Ukwaja KN
    Prevalence of drug-resistant tuberculosis in Nigeria: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0180996.
    PubMed     Text format     Abstract available


  463. MAGEE MJ, Sun YV, Brust JCM, Shah NS, et al
    Polymorphisms in the vitamin D receptor gene are associated with reduced rate of sputum culture conversion in multidrug-resistant tuberculosis patients in South Africa.
    PLoS One. 2017;12:e0180916.
    PubMed     Text format     Abstract available


  464. SIMA BT, Belachew T, Abebe F
    Knowledge, attitude and perceived stigma towards tuberculosis among pastoralists; Do they differ from sedentary communities? A comparative cross-sectional study.
    PLoS One. 2017;12:e0181032.
    PubMed     Text format     Abstract available


  465. KO Y, Song J, Lee SY, Moon JW, et al
    Does repeated pleural culture increase the diagnostic yield of Mycobacterium tuberculosis from tuberculous pleural effusion in HIV-negative individuals?
    PLoS One. 2017;12:e0181798.
    PubMed     Text format     Abstract available


  466. JEON AB, Obregon-Henao A, Ackart DF, Podell BK, et al
    2-aminoimidazoles potentiate ss-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ss-lactamase secretion and increasing cell envelope permeability.
    PLoS One. 2017;12:e0180925.
    PubMed     Text format     Abstract available


  467. EVANS D, Schnippel K, Govathson C, Sineke T, et al
    Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa.
    PLoS One. 2017;12:e0181238.
    PubMed     Text format     Abstract available


  468. MYLLYMAKI H, Niskanen M, Oksanen KE, Sherwood E, et al
    Identification of novel antigen candidates for a tuberculosis vaccine in the adult zebrafish (Danio rerio).
    PLoS One. 2017;12:e0181942.
    PubMed     Text format     Abstract available


  469. HANIFA Y, Fielding KL, Chihota VN, Adonis L, et al
    A clinical scoring system to prioritise investigation for tuberculosis among adults attending HIV clinics in South Africa.
    PLoS One. 2017;12:e0181519.
    PubMed     Text format     Abstract available



  470. Correction: A scoring system to effectively evaluate central nervous system tuberculosis in patients with miliary tuberculosis.
    PLoS One. 2017;12:e0182713.
    PubMed     Text format     Abstract available


  471. SHETE PB, Ravindran R, Chang E, Worodria W, et al
    Evaluation of antibody responses to panels of M. tuberculosis antigens as a screening tool for active tuberculosis in Uganda.
    PLoS One. 2017;12:e0180122.
    PubMed     Text format     Abstract available


  472. SZKWARKO D, Hirsch-Moverman Y, Du Plessis L, Du Preez K, et al
    Child contact management in high tuberculosis burden countries: A mixed-methods systematic review.
    PLoS One. 2017;12:e0182185.
    PubMed     Text format     Abstract available


  473. GETAHUN B, Nkosi ZZ
    Is directly observed tuberculosis treatment strategy patient-centered? A mixed method study in Addis Ababa, Ethiopia.
    PLoS One. 2017;12:e0181205.
    PubMed     Text format     Abstract available


  474. SERI B, Koffi A, Danel C, Ouassa T, et al
    Prevalence of pulmonary tuberculosis among prison inmates: A cross-sectional survey at the Correctional and Detention Facility of Abidjan, Cote d'Ivoire.
    PLoS One. 2017;12:e0181995.
    PubMed     Text format     Abstract available


  475. RIVIERE J, Le Strat Y, Hendrikx P, Dufour B, et al
    Cost-effectiveness evaluation of bovine tuberculosis surveillance in wildlife in France (Sylvatub system) using scenario trees.
    PLoS One. 2017;12:e0183126.
    PubMed     Text format     Abstract available


  476. FONSECA BPFE, Silva MVPD, Araujo KM, Sampaio RB, et al
    Network analysis for science and technology management: Evidence from tuberculosis research in Fiocruz, Brazil.
    PLoS One. 2017;12:e0181870.
    PubMed     Text format     Abstract available


  477. MALEKINEJAD M, Parriott A, Viitanen AP, Horvath H, et al
    Yield of community-based tuberculosis targeted testing and treatment in foreign-born populations in the United States: A systematic review.
    PLoS One. 2017;12:e0180707.
    PubMed     Text format     Abstract available


  478. FARLEY JE, Ndjeka N, Kelly AM, Whitehouse E, et al
    Evaluation of a nurse practitioner-physician task-sharing model for multidrug-resistant tuberculosis in South Africa.
    PLoS One. 2017;12:e0182780.
    PubMed     Text format     Abstract available


  479. MANDALAKAS AM, Ngo K, Alonso Ustero P, Golin R, et al
    BUTIMBA: Intensifying the Hunt for Child TB in Swaziland through Household Contact Tracing.
    PLoS One. 2017;12:e0169769.
    PubMed     Text format     Abstract available


  480. LIU H, Zheng R, Wang P, Yang H, et al
    IL-37 Confers Protection against Mycobacterial Infection Involving Suppressing Inflammation and Modulating T Cell Activation.
    PLoS One. 2017;12:e0169922.
    PubMed     Text format     Abstract available


  481. HAMEED S, Moganeradj K, Mahmood N, McHugh TD, et al
    Sequence analysis of the rifampicin resistance determining region (RRDR) of rpoB gene in multidrug resistance confirmed and newly diagnosed tuberculosis patients of Punjab, Pakistan.
    PLoS One. 2017;12:e0183363.
    PubMed     Text format     Abstract available


  482. TRIPP L, Sawchuk LA
    Insights into secular trends of respiratory tuberculosis: The 20th century Maltese experience.
    PLoS One. 2017;12:e0183296.
    PubMed     Text format     Abstract available


  483. ADAMU AL, Aliyu MH, Galadanci NA, Musa BM, et al
    Deaths during tuberculosis treatment among paediatric patients in a large tertiary hospital in Nigeria.
    PLoS One. 2017;12:e0183270.
    PubMed     Text format     Abstract available


  484. SUBBARAMAN R, Thomas BE, Sellappan S, Suresh C, et al
    Tuberculosis patients in an Indian mega-city: Where do they live and where are they diagnosed?
    PLoS One. 2017;12:e0183240.
    PubMed     Text format     Abstract available


  485. CASTRO-GARZA J, Garcia-Jacobo P, Rivera-Morales LG, Quinn FD, et al
    Detection of anti-HspX antibodies and HspX protein in patient sera for the identification of recent latent infection by Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0181714.
    PubMed     Text format     Abstract available


  486. JONES A, Pitts M, Al Dulayymi JR, Gibbons J, et al
    New synthetic lipid antigens for rapid serological diagnosis of tuberculosis.
    PLoS One. 2017;12:e0181414.
    PubMed     Text format     Abstract available


  487. REYES-ALDASORO CC
    The proportion of cancer-related entries in PubMed has increased considerably; is cancer truly "The Emperor of All Maladies"?
    PLoS One. 2017;12:e0173671.
    PubMed     Text format     Abstract available


  488. KIMARO GD, Mfinanga S, Simms V, Kivuyo S, et al
    The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies.
    PLoS One. 2017;12:e0171917.
    PubMed     Text format     Abstract available


  489. HUERGA H, Ferlazzo G, Bevilacqua P, Kirubi B, et al
    Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya.
    PLoS One. 2017;12:e0170976.
    PubMed     Text format     Abstract available


  490. CHIACCHIO T, Delogu G, Vanini V, Cuzzi G, et al
    Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection.
    PLoS One. 2017;12:e0183846.
    PubMed     Text format     Abstract available


  491. HOCHBERG NS, Sarkar S, Horsburgh CR Jr, Knudsen S, et al
    Comorbidities in pulmonary tuberculosis cases in Puducherry and Tamil Nadu, India: Opportunities for intervention.
    PLoS One. 2017;12:e0183195.
    PubMed     Text format     Abstract available


  492. SINGH BK, Sharma SK, Sharma R, Sreenivas V, et al
    Diagnostic utility of a line probe assay for multidrug resistant-TB in smear-negative pulmonary tuberculosis.
    PLoS One. 2017;12:e0182988.
    PubMed     Text format     Abstract available


  493. ESPINOSA-CUETO P, Magallanes-Puebla A, Castellanos C, Mancilla R, et al
    Dendritic cells that phagocytose apoptotic macrophages loaded with mycobacterial antigens activate CD8 T cells via cross-presentation.
    PLoS One. 2017;12:e0182126.
    PubMed     Text format     Abstract available


  494. HAIMOVICH JS, Venkatesh AK, Shojaee A, Coppi A, et al
    Discovery of temporal and disease association patterns in condition-specific hospital utilization rates.
    PLoS One. 2017;12:e0172049.
    PubMed     Text format     Abstract available


  495. HATTHAKAROON C, Pharkjaksu S, Chongtrakool P, Suwannakarn K, et al
    Molecular epidemiology of cryptococcal genotype VNIc/ST5 in Siriraj Hospital, Thailand.
    PLoS One. 2017;12:e0173744.
    PubMed     Text format     Abstract available


  496. BRUFFAERTS N, Vluggen C, Roupie V, Duytschaever L, et al
    Virulence and immunogenicity of genetically defined human and porcine isolates of M. avium subsp. hominissuis in an experimental mouse infection.
    PLoS One. 2017;12:e0171895.
    PubMed     Text format     Abstract available


  497. BAGUMA R, Penn-Nicholson A, Smit E, Erasmus M, et al
    Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population.
    PLoS One. 2017;12:e0184563.
    PubMed     Text format     Abstract available


  498. MARANGU D, Mwaniki H, Nduku S, Maleche-Obimbo E, et al
    Stakeholder perspectives for optimization of tuberculosis contact investigation in a high-burden setting.
    PLoS One. 2017;12:e0183749.
    PubMed     Text format     Abstract available


  499. PHILLIPS BL, Gautam US, Bucsan AN, Foreman TW, et al
    LAG-3 potentiates the survival of Mycobacterium tuberculosis in host phagocytes by modulating mitochondrial signaling in an in-vitro granuloma model.
    PLoS One. 2017;12:e0180413.
    PubMed     Text format     Abstract available


  500. KHAPARDE S, Raizada N, Nair SA, Denkinger C, et al
    Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysis.
    PLoS One. 2017;12:e0184270.
    PubMed     Text format     Abstract available


  501. TKACHUK AP, Gushchin VA, Potapov VD, Demidenko AV, et al
    Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models.
    PLoS One. 2017;12:e0176784.
    PubMed     Text format     Abstract available


  502. GETAHUN B, Nkosi ZZ
    Satisfaction of patients with directly observed treatment strategy in Addis Ababa, Ethiopia: A mixed-methods study.
    PLoS One. 2017;12:e0171209.
    PubMed     Text format     Abstract available


  503. CLOUSE K, Blevins M, Lindegren ML, Yotebieng M, et al
    Low implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program.
    PLoS One. 2017;12:e0171384.
    PubMed     Text format     Abstract available


  504. MONTANE E, Barriocanal AM, Arellano AL, Valderrama A, et al
    Pilot, double-blind, randomized, placebo-controlled clinical trial of the supplement food Nyaditum resae(R) in adults with or without latent TB infection: Safety and immunogenicity.
    PLoS One. 2017;12:e0171294.
    PubMed     Text format     Abstract available


  505. KUMAR NP, Moideen K, Viswanathan V, Sivakumar S, et al
    Heightened circulating levels of antimicrobial peptides in tuberculosis-Diabetes co-morbidity and reversal upon treatment.
    PLoS One. 2017;12:e0184753.
    PubMed     Text format     Abstract available


  506. CUI JY, Liang HW, Pan XL, Li D, et al
    Characterization of a novel panel of plasma microRNAs that discriminates between Mycobacterium tuberculosis infection and healthy individuals.
    PLoS One. 2017;12:e0184113.
    PubMed     Text format     Abstract available


  507. BLANCO-GUILLOT F, Delgado-Sanchez G, Mongua-Rodriguez N, Cruz-Hervert P, et al
    Molecular clustering of patients with diabetes and pulmonary tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0184675.
    PubMed     Text format     Abstract available


  508. BLOCH-INFANGER C, Battig V, Kremo J, Widmer AF, et al
    Increasing prevalence of infectious diseases in asylum seekers at a tertiary care hospital in Switzerland.
    PLoS One. 2017;12:e0179537.
    PubMed     Text format     Abstract available


  509. SALAME FM, Ferreira MD, Belo MT, Teixeira EG, et al
    Knowledge about tuberculosis transmission and prevention and perceptions of health service utilization among index cases and contacts in Brazil: Understanding losses in the latent tuberculosis cascade of care.
    PLoS One. 2017;12:e0184061.
    PubMed     Text format     Abstract available


  510. SENGHORE M, Otu J, Witney A, Gehre F, et al
    Whole-genome sequencing illuminates the evolution and spread of multidrug-resistant tuberculosis in Southwest Nigeria.
    PLoS One. 2017;12:e0184510.
    PubMed     Text format     Abstract available


  511. ZHANG C, Ruan Y, Cheng J, Zhao F, et al
    Comparing yield and relative costs of WHO TB screening algorithms in selected risk groups among people aged 65 years and over in China, 2013.
    PLoS One. 2017;12:e0176581.
    PubMed     Text format     Abstract available


  512. ABONGOMERA C, Ritmeijer K, Vogt F, Buyze J, et al
    Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia.
    PLoS One. 2017;12:e0178996.
    PubMed     Text format     Abstract available


  513. TAVARES AM, Fronteira I, Couto I, Machado D, et al
    HIV and tuberculosis co-infection among migrants in Europe: A systematic review on the prevalence, incidence and mortality.
    PLoS One. 2017;12:e0185526.
    PubMed     Text format     Abstract available


  514. LARSON EC, Novis CL, Martins LJ, Macedo AB, et al
    Mycobacterium tuberculosis reactivates latent HIV-1 in T cells in vitro.
    PLoS One. 2017;12:e0185162.
    PubMed     Text format     Abstract available


  515. BONADONNA LV, Saunders MJ, Zegarra R, Evans C, et al
    Why wait? The social determinants underlying tuberculosis diagnostic delay.
    PLoS One. 2017;12:e0185018.
    PubMed     Text format     Abstract available


  516. MUSA BM, Adamu AL, Galadanci NA, Zubayr B, et al
    Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0185105.
    PubMed     Text format     Abstract available


  517. SHIM EJ, Lee KM, Kim EJ, Kim HG, et al
    CT pattern analysis of necrotizing and nonnecrotizing lymph nodes in Kikuchi disease.
    PLoS One. 2017;12:e0181169.
    PubMed     Text format     Abstract available


  518. SHIN HJ, Kim TO, Oh HJ, Park HY, et al
    Impact of diabetes mellitus on indeterminate results of the QuantiFERON TB Gold In-Tube test: A propensity score matching analysis.
    PLoS One. 2017;12:e0181887.
    PubMed     Text format     Abstract available


  519. LETH C, Varadharajan A, Mester P, Fischaleck M, et al
    Matrixlysis, an improved sample preparation method for recovery of Mycobacteria from animal tissue material.
    PLoS One. 2017;12:e0181157.
    PubMed     Text format     Abstract available


  520. EMUKULE GO, Spreeuwenberg P, Chaves SS, Mott JA, et al
    Estimating influenza and respiratory syncytial virus-associated mortality in Western Kenya using health and demographic surveillance system data, 2007-2013.
    PLoS One. 2017;12:e0180890.
    PubMed     Text format     Abstract available


  521. SHIN HJ, Franco LH, Nair VR, Collins AC, et al
    A baculovirus-conjugated mimotope vaccine targeting Mycobacterium tuberculosis lipoarabinomannan.
    PLoS One. 2017;12:e0185945.
    PubMed     Text format     Abstract available


  522. TYLER AD, Randell E, Baikie M, Antonation K, et al
    Application of whole genome sequence analysis to the study of Mycobacterium tuberculosis in Nunavut, Canada.
    PLoS One. 2017;12:e0185656.
    PubMed     Text format     Abstract available


  523. MEKONNEN E, Bekele E
    An ancestral human genetic variant linked to an ancient disease: A novel association of FMO2 polymorphisms with tuberculosis (TB) in Ethiopian populations provides new insight into the differential ethno-geographic distribution of FMO2*1.
    PLoS One. 2017;12:e0184931.
    PubMed     Text format     Abstract available


  524. YU EA, John SH, Tablante EC, King CA, et al
    Host transcriptional responses following ex vivo re-challenge with Mycobacterium tuberculosis vary with disease status.
    PLoS One. 2017;12:e0185640.
    PubMed     Text format     Abstract available


  525. BOIREAU C, Dufour B, Praud A
    The importance of communication in promoting voluntary participation in an experimental trial: A qualitative study based on the assessment of the gamma-interferon test for the diagnosis of bovine tuberculosis in France.
    PLoS One. 2017;12:e0185799.
    PubMed     Text format     Abstract available


  526. WANG X, Jiang H, Wang X, Liu H, et al
    ESMPE: A combined strategy for school tuberculosis prevention and control proposed by Dalian, China.
    PLoS One. 2017;12:e0185646.
    PubMed     Text format     Abstract available


  527. THERON A, Roth RL, Hoppe H, Parkinson C, et al
    Differential inhibition of adenylylated and deadenylylated forms of M. tuberculosis glutamine synthetase as a drug discovery platform.
    PLoS One. 2017;12:e0185068.
    PubMed     Text format     Abstract available


  528. MAILANKODY S, Dangeti GV, Soundravally R, Joseph NM, et al
    Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis.
    PLoS One. 2017;12:e0181262.
    PubMed     Text format     Abstract available


  529. MICHEL AL, Lane EP, de Klerk-Lorist LM, Hofmeyr M, et al
    Experimental Mycobacterium bovis infection in three white rhinoceroses (Ceratotherium simum): Susceptibility, clinical and anatomical pathology.
    PLoS One. 2017;12:e0179943.
    PubMed     Text format     Abstract available


  530. ELLIS CK, Rice S, Maurer D, Stahl R, et al
    Use of fecal volatile organic compound analysis to discriminate between non-vaccinated and BCG-Vaccinated cattle prior to and after Mycobacterium bovis challenge.
    PLoS One. 2017;12:e0179914.
    PubMed     Text format     Abstract available


  531. RICE JP, Seifert M, Moser KS, Rodwell TC, et al
    Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting.
    PLoS One. 2017;12:e0186139.
    PubMed     Text format     Abstract available


  532. RENIERS G, Blom S, Lieber J, Herbst AJ, et al
    Tuberculosis mortality and the male survival deficit in rural South Africa: An observational community cohort study.
    PLoS One. 2017;12:e0185692.
    PubMed     Text format     Abstract available


  533. PATI S, Swain S, Metsemakers J, Knottnerus JA, et al
    Pattern and severity of multimorbidity among patients attending primary care settings in Odisha, India.
    PLoS One. 2017;12:e0183966.
    PubMed     Text format     Abstract available


  534. MINDU C, Lopez-Varela E, Alonso-Menendez Y, Mausse Y, et al
    Caretakers' perspectives of paediatric TB and implications for care-seeking behaviours in Southern Mozambique.
    PLoS One. 2017;12:e0182213.
    PubMed     Text format     Abstract available


  535. SCHECHTER MC, Buac K, Adekambi T, Cagle S, et al
    Neutrophil extracellular trap (NET) levels in human plasma are associated with active TB.
    PLoS One. 2017;12:e0182587.
    PubMed     Text format     Abstract available


  536. RASOAHANITRALISOA R, Rakotosamimanana N, Stucki D, Sola C, et al
    Evaluation of spoligotyping, SNPs and customised MIRU-VNTR combination for genotyping Mycobacterium tuberculosis clinical isolates in Madagascar.
    PLoS One. 2017;12:e0186088.
    PubMed     Text format     Abstract available


  537. HIJIKATA M, Keicho N, Duc LV, Maeda S, et al
    Spoligotyping and whole-genome sequencing analysis of lineage 1 strains of Mycobacterium tuberculosis in Da Nang, Vietnam.
    PLoS One. 2017;12:e0186800.
    PubMed     Text format     Abstract available


  538. SCHNEEFELD M, Busche T, Geffers R, Kalinowski J, et al
    The transcriptional regulator LysG (Rv1985c) of Mycobacterium tuberculosis activates lysE (Rv1986) in a lysine-dependent manner.
    PLoS One. 2017;12:e0186505.
    PubMed     Text format     Abstract available


  539. CHAN SL, Chua APG, Aminkeng F, Chee CBE, et al
    Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients.
    PLoS One. 2017;12:e0186200.
    PubMed     Text format     Abstract available


  540. KAPWATA T, Morris N, Campbell A, Mthiyane T, et al
    Spatial distribution of extensively drug-resistant tuberculosis (XDR TB) patients in KwaZulu-Natal, South Africa.
    PLoS One. 2017;12:e0181797.
    PubMed     Text format     Abstract available


  541. HSIAO CY, Chiu HY, Wang TS, Tsai TF, et al
    Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab.
    PLoS One. 2017;12:e0184178.
    PubMed     Text format     Abstract available


  542. BELLO G, Faragher B, Sanudi L, Namakhoma I, et al
    The effect of engaging unpaid informal providers on case detection and treatment initiation rates for TB and HIV in rural Malawi (Triage Plus): A cluster randomised health system intervention trial.
    PLoS One. 2017;12:e0183312.
    PubMed     Text format     Abstract available


  543. MUNOZ L, Gonzalez L, Soldevila L, Dorca J, et al
    QuantiFERON(R)-TB Gold In-Tube for contact screening in BCG-vaccinated adults: A longitudinal cohort study.
    PLoS One. 2017;12:e0183258.
    PubMed     Text format     Abstract available


  544. HAVLICEK J, Rivera-Milla E, Slickers P, Andres S, et al
    An application of competitive reporter monitored amplification (CMA) for rapid detection of single nucleotide polymorphisms (SNPs).
    PLoS One. 2017;12:e0183561.
    PubMed     Text format     Abstract available


  545. ALTET N, Latorre I, Jimenez-Fuentes MA, Maldonado J, et al
    Assessment of the influence of direct tobacco smoke on infection and active TB management.
    PLoS One. 2017;12:e0182998.
    PubMed     Text format     Abstract available


  546. AGIZEW T, Boyd R, Ndwapi N, Auld A, et al
    Peripheral clinic versus centralized laboratory-based Xpert MTB/RIF performance: Experience gained from a pragmatic, stepped-wedge trial in Botswana.
    PLoS One. 2017;12:e0183237.
    PubMed     Text format     Abstract available


  547. CHENG AC, Yang KY, Chen NJ, Hsu TL, et al
    CLEC9A modulates macrophage-mediated neutrophil recruitment in response to heat-killed Mycobacterium tuberculosis H37Ra.
    PLoS One. 2017;12:e0186780.
    PubMed     Text format     Abstract available


  548. VINNARD C, Ravimohan S, Tamuhla N, Pasipanodya J, et al
    Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation.
    PLoS One. 2017;12:e0187624.
    PubMed     Text format     Abstract available


  549. KAWATSU L, Uchimura K, Ohkado A
    Trend and treatment status of latent tuberculosis infection patients in Japan - Analysis of Japan TB Surveillance data.
    PLoS One. 2017;12:e0186588.
    PubMed     Text format     Abstract available


  550. CARCELEN M, Abascal E, Herranz M, Santanton S, et al
    Optimizing and accelerating the assignation of lineages in Mycobacterium tuberculosis using novel alternative single-tube assays.
    PLoS One. 2017;12:e0186956.
    PubMed     Text format     Abstract available


  551. NGABONZIZA JCS, Diallo AB, Tagliani E, Diarra B, et al
    Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.
    PLoS One. 2017;12:e0187211.
    PubMed     Text format     Abstract available


  552. XU L, Chen J, Innes AL, Li L, et al
    Prescription practice of anti-tuberculosis drugs in Yunnan, China: A clinical audit.
    PLoS One. 2017;12:e0187076.
    PubMed     Text format     Abstract available


  553. CAMPBELL JR, Johnston JC, Sadatsafavi M, Cook VJ, et al
    Cost-effectiveness of post-landing latent tuberculosis infection control strategies in new migrants to Canada.
    PLoS One. 2017;12:e0186778.
    PubMed     Text format     Abstract available


  554. FELDACKER C, Pintye J, Jacob S, Chung MH, et al
    Continuing professional development for medical, nursing, and midwifery cadres in Malawi, Tanzania and South Africa: A qualitative evaluation.
    PLoS One. 2017;12:e0186074.
    PubMed     Text format     Abstract available


  555. DANYUTTAPOLCHAI J, Kittimunkong S, Nateniyom S, Painujit S, et al
    Implementing an isoniazid preventive therapy program for people living with HIV in Thailand.
    PLoS One. 2017;12:e0184986.
    PubMed     Text format     Abstract available


  556. HERZMANN C, Ernst M, Lange C, Stenger S, et al
    Pulmonary immune responses to Mycobacterium tuberculosis in exposed individuals.
    PLoS One. 2017;12:e0187882.
    PubMed     Text format     Abstract available


  557. HE X, Cao M, Mahapatra T, Du X, et al
    Burden of tuberculosis in Xinjiang between 2011 and 2015: A surveillance data-based study.
    PLoS One. 2017;12:e0187592.
    PubMed     Text format     Abstract available


  558. ARMSTRONG-HOUGH M, Turimumahoro P, Meyer AJ, Ochom E, et al
    Drop-out from the tuberculosis contact investigation cascade in a routine public health setting in urban Uganda: A prospective, multi-center study.
    PLoS One. 2017;12:e0187145.
    PubMed     Text format     Abstract available


  559. ONYANGO DO, Yuen CM, Cain KP, Ngari F, et al
    Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya.
    PLoS One. 2017;12:e0188235.
    PubMed     Text format     Abstract available


  560. HEMINGWAY C, Berk M, Anderson ST, Wright VJ, et al
    Childhood tuberculosis is associated with decreased abundance of T cell gene transcripts and impaired T cell function.
    PLoS One. 2017;12:e0185973.
    PubMed     Text format     Abstract available


  561. PATEL S, Paulsen C, Heffernan C, Saunders D, et al
    Tuberculosis transmission in the Indigenous peoples of the Canadian prairies.
    PLoS One. 2017;12:e0188189.
    PubMed     Text format     Abstract available


  562. SHEWADE HD, Jeyashree K, Mahajan P, Shah AN, et al
    Effect of glycemic control and type of diabetes treatment on unsuccessful TB treatment outcomes among people with TB-Diabetes: A systematic review.
    PLoS One. 2017;12:e0186697.
    PubMed     Text format     Abstract available


  563. RANZANI OT, Rodrigues LC, Waldman EA, Carvalho CRR, et al
    Estimating the impact of tuberculosis anatomical classification on treatment outcomes: A patient and surveillance perspective analysis.
    PLoS One. 2017;12:e0187585.
    PubMed     Text format     Abstract available


  564. ANDRES M, Gohring-Zwacka E, Fiebig L, Priwitzer M, et al
    Integration of molecular typing results into tuberculosis surveillance in Germany-A pilot study.
    PLoS One. 2017;12:e0188356.
    PubMed     Text format     Abstract available


  565. AL-RIFAI RH, Pearson F, Critchley JA, Abu-Raddad LJ, et al
    Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0187967.
    PubMed     Text format     Abstract available


  566. SOTGIU G, Falzon D, Hollo V, Kodmon C, et al
    Determinants of site of tuberculosis disease: An analysis of European surveillance data from 2003 to 2014.
    PLoS One. 2017;12:e0186499.
    PubMed     Text format     Abstract available


  567. SON HJ, Sung H, Park SY, Kim T, et al
    Diagnostic performance of the (1-3)-beta-D-glucan assay in patients with Pneumocystis jirovecii compared with those with candidiasis, aspergillosis, mucormycosis, and tuberculosis, and healthy volunteers.
    PLoS One. 2017;12:e0188860.
    PubMed     Text format     Abstract available


  568. DOAN TN, Eisen DP, Rose MT, Slack A, et al
    Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
    PLoS One. 2017;12:e0188631.
    PubMed     Text format     Abstract available


  569. MCMURTREY C, Harriff MJ, Swarbrick GM, Duncan A, et al
    T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells.
    PLoS One. 2017;12:e0188288.
    PubMed     Text format     Abstract available


  570. SUN Y, Chen J, Li J, Xu Y, et al
    Novel approach based on one-tube nested PCR and a lateral flow strip for highly sensitive diagnosis of tuberculous meningitis.
    PLoS One. 2017;12:e0186985.
    PubMed     Text format     Abstract available


  571. LATORRE I, Minguez S, Carrascosa JM, Naves J, et al
    Immune-mediated inflammatory diseases differently affect IGRAs' accuracy for latent tuberculosis infection diagnosis in clinical practice.
    PLoS One. 2017;12:e0189202.
    PubMed     Text format     Abstract available


  572. MAVE V, Kinikar A, Kagal A, Nimkar S, et al
    Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis.
    PLoS One. 2017;12:e0189101.
    PubMed     Text format     Abstract available


  573. LAVANIA S, Anthwal D, Bhalla M, Singh N, et al
    Direct detection of Mycobacterium tuberculosis rifampin resistance in bio-safe stained sputum smears.
    PLoS One. 2017;12:e0189149.
    PubMed     Text format     Abstract available


  574. FLICK RJ, Munthali A, Simon K, Hosseinipour M, et al
    Assessing infection control practices to protect health care workers and patients in Malawi from nosocomial transmission of Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0189140.
    PubMed     Text format     Abstract available


  575. KIMUDA SG, Andia-Biraro I, Egesa M, Bagaya BS, et al
    Use of QuantiFERON(R)-TB Gold in-tube culture supernatants for measurement of antibody responses.
    PLoS One. 2017;12:e0188396.
    PubMed     Text format     Abstract available


  576. JONSSON J, Westman A, Bruchfeld J, Sturegard E, et al
    A borderline range for Quantiferon Gold In-Tube results.
    PLoS One. 2017;12:e0187313.
    PubMed     Text format     Abstract available


  577. SINGH B, Saqib M, Gupta A, Kumar P, et al
    Autophagy induction by Mycobacterium indicus pranii promotes Mycobacterium tuberculosis clearance from RAW 264.7 macrophages.
    PLoS One. 2017;12:e0189606.
    PubMed     Text format     Abstract available


  578. GRANDJEAN L, Gilman RH, Iwamoto T, Koser CU, et al
    Convergent evolution and topologically disruptive polymorphisms among multidrug-resistant tuberculosis in Peru.
    PLoS One. 2017;12:e0189838.
    PubMed     Text format     Abstract available


  579. PITTALIS S, Piselli P, Contini S, Gualano G, et al
    Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy.
    PLoS One. 2017;12:e0189425.
    PubMed     Text format     Abstract available


  580. BANDA HT, Thomson R, Mortimer K, Bello GAF, et al
    Community prevalence of chronic respiratory symptoms in rural Malawi: Implications for policy.
    PLoS One. 2017;12:e0188437.
    PubMed     Text format     Abstract available


  581. YU G, Ye B, Chen D, Zhong F, et al
    Comparison between the diagnostic validities of Xpert MTB/RIF and interferon-gamma release assays for tuberculous pericarditis using pericardial tissue.
    PLoS One. 2017;12:e0188704.
    PubMed     Text format     Abstract available


  582. VAN DER HEIJDEN EMDL, Chileshe J, Vernooij JCM, Gortazar C, et al
    Immune response profiles of calves following vaccination with live BCG and inactivated Mycobacterium bovis vaccine candidates.
    PLoS One. 2017;12:e0188448.
    PubMed     Text format     Abstract available


  583. KIM Y, Kim BK, Choi HJ, Ryu SW, et al
    Lessons learned from continued TB outbreaks in a high school.
    PLoS One. 2017;12:e0188076.
    PubMed     Text format     Abstract available


  584. WAI PP, Shewade HD, Kyaw NTT, Kyaw KWY, et al
    Patients with MDR-TB on domiciliary care in programmatic settings in Myanmar: Effect of a support package on preventing early deaths.
    PLoS One. 2017;12:e0187223.
    PubMed     Text format     Abstract available


    January 2016
  585. BASTOS HN, Osorio NS, Castro AG, Ramos A, et al
    A Prediction Rule to Stratify Mortality Risk of Patients with Pulmonary Tuberculosis.
    PLoS One. 2016;11:e0162797.
    PubMed     Text format     Abstract available


  586. FAGUNDEZ G, Perez-Freixo H, Eyene J, Momo JC, et al
    Treatment Adherence of Tuberculosis Patients Attending Two Reference Units in Equatorial Guinea.
    PLoS One. 2016;11:e0161995.
    PubMed     Text format     Abstract available


  587. AYUBI E, Doosti-Irani A, Sanjari Moghaddam A, Sani M, et al
    The Clinical Usefulness of Tuberculin Skin Test versus Interferon-Gamma Release Assays for Diagnosis of Latent Tuberculosis in HIV Patients: A Meta-Analysis.
    PLoS One. 2016;11:e0161983.
    PubMed     Text format     Abstract available


  588. MORISHITA F, Yadav RP, Eang MT, Saint S, et al
    Mitigating Financial Burden of Tuberculosis through Active Case Finding Targeting Household and Neighbourhood Contacts in Cambodia.
    PLoS One. 2016;11:e0162796.
    PubMed     Text format     Abstract available


  589. SSENGOOBA W, Respeito D, Mambuque E, Blanco S, et al
    Do Xpert MTB/RIF Cycle Threshold Values Provide Information about Patient Delays for Tuberculosis Diagnosis?
    PLoS One. 2016;11:e0162833.
    PubMed     Text format     Abstract available


  590. MEHTA S, Das M, Laxmeshwar C, Jonckheere S, et al
    Linezolid-Associated Optic Neuropathy in Drug-Resistant Tuberculosis Patients in Mumbai, India.
    PLoS One. 2016;11:e0162138.
    PubMed     Text format     Abstract available


  591. AULD E, Lin J, Chang E, Byanyima P, et al
    HIV Infection Is Associated with Shortened Telomere Length in Ugandans with Suspected Tuberculosis.
    PLoS One. 2016;11:e0163153.
    PubMed     Text format     Abstract available


  592. FORST J, Brown TA
    Inability of 'Whole Genome Amplification' to Improve Success Rates for the Biomolecular Detection of Tuberculosis in Archaeological Samples.
    PLoS One. 2016;11:e0163031.
    PubMed     Text format     Abstract available


  593. KHALID R, Afzal M, Khurshid S, Paracha RZ, et al
    Fusion Molecules of Heat Shock Protein HSPX with Other Antigens of Mycobacterium tuberculosis Show High Potential in Serodiagnosis of Tuberculosis.
    PLoS One. 2016;11:e0163349.
    PubMed     Text format     Abstract available


  594. NARENDRAN G, Kavitha D, Karunaianantham R, Gil-Santana L, et al
    Role of LTA4H Polymorphism in Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome Occurrence and Clinical Severity in Patients Infected with HIV.
    PLoS One. 2016;11:e0163298.
    PubMed     Text format     Abstract available


  595. TURINAWE K, Vandebriel G, Lowrance DW, Uwinkindi F, et al
    Operating Characteristics of a Tuberculosis Screening Tool for People Living with HIV in Out-Patient HIV Care and Treatment Services, Rwanda.
    PLoS One. 2016;11:e0163462.
    PubMed     Text format     Abstract available


  596. WERGELAND I, Assmus J, Dyrhol-Riise AM
    Cytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls.
    PLoS One. 2016;11:e0163848.
    PubMed     Text format     Abstract available


  597. STREATA I, Weiner J 3rd, Iannaconne M, McEwen G, et al
    The CARD9 Polymorphisms rs4077515, rs10870077 and rs10781499 Are Uncoupled from Susceptibility to and Severity of Pulmonary Tuberculosis.
    PLoS One. 2016;11:e0163662.
    PubMed     Text format     Abstract available


  598. CHANDA-KAPATA P, Kapata N, Masiye F, Maboshe M, et al
    Health Seeking Behaviour among Individuals with Presumptive Tuberculosis in Zambia.
    PLoS One. 2016;11:e0163975.
    PubMed     Text format     Abstract available


  599. NASREEN S, Shokoohi M, Malvankar-Mehta MS
    Prevalence of Latent Tuberculosis among Health Care Workers in High Burden Countries: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0164034.
    PubMed     Text format     Abstract available


  600. CHOI HG, Choi S, Back YW, Park HS, et al
    Mycobacterium tuberculosis Rv2882c Protein Induces Activation of Macrophages through TLR4 and Exhibits Vaccine Potential.
    PLoS One. 2016;11:e0164458.
    PubMed     Text format     Abstract available


  601. OMBURA IP, Onyango N, Odera S, Mutua F, et al
    Prevalence of Drug Resistance Mycobacterium Tuberculosis among Patients Seen in Coast Provincial General Hospital, Mombasa, Kenya.
    PLoS One. 2016;11:e0163994.
    PubMed     Text format     Abstract available


  602. MASINI EO, Mansour O, Speer CE, Addona V, et al
    Using Survival Analysis to Identify Risk Factors for Treatment Interruption among New and Retreatment Tuberculosis Patients in Kenya.
    PLoS One. 2016;11:e0164172.
    PubMed     Text format     Abstract available


  603. LEE SH, Kwon AM, Yang HC, Lee SK, et al
    Longitudinal Lung Function Decrease in Subjects with Spontaneous Healed Pulmonary Tuberculosis.
    PLoS One. 2016;11:e0164039.
    PubMed     Text format     Abstract available


  604. BLANKLEY S, Graham CM, Turner J, Berry MP, et al
    The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis.
    PLoS One. 2016;11:e0162220.
    PubMed     Text format     Abstract available


  605. ZURCHER K, Zwahlen M, Ballif M, Rieder HL, et al
    Influenza Pandemics and Tuberculosis Mortality in 1889 and 1918: Analysis of Historical Data from Switzerland.
    PLoS One. 2016;11:e0162575.
    PubMed     Text format     Abstract available


  606. SANAIE A, Mergenthaler C, Nasrat A, Seddiq MK, et al
    An Evaluation of Passive and Active Approaches to Improve Tuberculosis Notifications in Afghanistan.
    PLoS One. 2016;11:e0163813.
    PubMed     Text format     Abstract available


  607. GURJAV U, Outhred AC, Jelfs P, McCallum N, et al
    Whole Genome Sequencing Demonstrates Limited Transmission within Identified Mycobacterium tuberculosis Clusters in New South Wales, Australia.
    PLoS One. 2016;11:e0163612.
    PubMed     Text format     Abstract available


  608. FLETCHER R, Jones JD, Shah NS
    Treatment of Active Tuberculosis in Chicago, 2008-2011: The Role of Public Health Departments.
    PLoS One. 2016;11:e0164162.
    PubMed     Text format     Abstract available


  609. MCLAREN ZM, Schnippel K, Sharp A
    A Data-Driven Evaluation of the Stop TB Global Partnership Strategy of Targeting Key Populations at Greater Risk for Tuberculosis.
    PLoS One. 2016;11:e0163083.
    PubMed     Text format     Abstract available


  610. MATHEW B, Hobrath JV, Ross L, Connelly MC, et al
    Screening and Development of New Inhibitors of FtsZ from M. Tuberculosis.
    PLoS One. 2016;11:e0164100.
    PubMed     Text format     Abstract available


  611. JO YS, Park JH, Lee JK, Heo EY, et al
    Discordance between MTB/RIF and Real-Time Tuberculosis-Specific Polymerase Chain Reaction Assay in Bronchial Washing Specimen and Its Clinical Implications.
    PLoS One. 2016;11:e0164923.
    PubMed     Text format     Abstract available



  612. Correction: The Clinical Usefulness of Tuberculin Skin Test versus Interferon-Gamma Release Assays for Diagnosis of Latent Tuberculosis in HIV Patients: A Meta-Analysis.
    PLoS One. 2016;11:e0165143.
    PubMed     Text format     Abstract available


  613. XIE J, Codd C, Mo K, He Y, et al
    Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-Analysis.
    PLoS One. 2016;11:e0164792.
    PubMed     Text format     Abstract available


  614. OSPINA JE, Orcau A, Millet JP, Ros M, et al
    Epidemiology of Tuberculosis in Immigrants in a Large City with Large-Scale Immigration (1991-2013).
    PLoS One. 2016;11:e0164736.
    PubMed     Text format     Abstract available


  615. MCCALLUM AD, Nyirenda D, Lora W, Khoo SH, et al
    Perceptions of Research Bronchoscopy in Malawian Adults with Pulmonary Tuberculosis: A Cross-Sectional Study.
    PLoS One. 2016;11:e0165734.
    PubMed     Text format     Abstract available


  616. CHOI H, Chon HR, Kim K, Kim S, et al
    Clinical and Laboratory Differences between Lymphocyte- and Neutrophil-Predominant Pleural Tuberculosis.
    PLoS One. 2016;11:e0165428.
    PubMed     Text format     Abstract available


  617. ZHOU F, Xu X, Wu S, Cui X, et al
    Influence of HLA-DRB1 Alleles on the Variations of Antibody Response to Tuberculosis Serodiagnostic Antigens in Active Tuberculosis Patients.
    PLoS One. 2016;11:e0165291.
    PubMed     Text format     Abstract available


  618. STREATA I, Weiner J Rd, Iannaccone M, McEwen G, et al
    Correction: The CARD9 Polymorphisms rs4077515, rs10870077 and rs10781499 Are Uncoupled from Susceptibility to and Severity of Pulmonary Tuberculosis.
    PLoS One. 2016;11:e0165853.
    PubMed     Text format     Abstract available


  619. PEREZ-PORCUNA TM, Pereira-da-Silva HD, Ascaso C, Malheiro A, et al
    Prevalence and Diagnosis of Latent Tuberculosis Infection in Young Children in the Absence of a Gold Standard.
    PLoS One. 2016;11:e0164181.
    PubMed     Text format     Abstract available


  620. ALVARO-MECA A, Diaz A, de Miguel Diez J, Resino R, et al
    Environmental Factors Related to Pulmonary Tuberculosis in HIV-Infected Patients in the Combined Antiretroviral Therapy (cART) Era.
    PLoS One. 2016;11:e0165944.
    PubMed     Text format     Abstract available


  621. BERHANU R, Schnippel K, Mohr E, Hirasen K, et al
    Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study.
    PLoS One. 2016;11:e0164974.
    PubMed     Text format     Abstract available


  622. BEKKER A, Schaaf HS, Draper HR, Kriel M, et al
    Tuberculosis Disease during Pregnancy and Treatment Outcomes in HIV-Infected and Uninfected Women at a Referral Hospital in Cape Town.
    PLoS One. 2016;11:e0164249.
    PubMed     Text format     Abstract available


  623. MOHAMMED S, Glennerster R, Khan AJ
    Impact of a Daily SMS Medication Reminder System on Tuberculosis Treatment Outcomes: A Randomized Controlled Trial.
    PLoS One. 2016;11:e0162944.
    PubMed     Text format     Abstract available


  624. SARKER M, Barua M, Guerra F, Saha A, et al
    Double Trouble: Prevalence and Factors Associated with Tuberculosis and Diabetes Comorbidity in Bangladesh.
    PLoS One. 2016;11:e0165396.
    PubMed     Text format     Abstract available


  625. LIM CH, Lin CH, Chen DY, Chen YM, et al
    One-Year Tuberculosis Risk in Rheumatoid Arthritis Patients Starting Their First Tumor Necrosis Factor Inhibitor Therapy from 2008 to 2012 in Taiwan: A Nationwide Population-Based Cohort Study.
    PLoS One. 2016;11:e0166339.
    PubMed     Text format     Abstract available


  626. KARAT AS, Omar T, von Gottberg A, Tlali M, et al
    Autopsy Prevalence of Tuberculosis and Other Potentially Treatable Infections among Adults with Advanced HIV Enrolled in Out-Patient Care in South Africa.
    PLoS One. 2016;11:e0166158.
    PubMed     Text format     Abstract available


  627. CHUANG PH, Wu MH, Fan SY, Lin KY, et al
    Population-Based Drug Resistance Surveillance of Multidrug-Resistant Tuberculosis in Taiwan, 2007-2014.
    PLoS One. 2016;11:e0165222.
    PubMed     Text format     Abstract available


  628. AIBANA O, Acharya X, Huang CC, Becerra MC, et al
    Nutritional Status and Tuberculosis Risk in Adult and Pediatric Household Contacts.
    PLoS One. 2016;11:e0166333.
    PubMed     Text format     Abstract available


  629. LIU Z, Gao Y, Yang H, Bao H, et al
    Impact of Hypoxia on Drug Resistance and Growth Characteristics of Mycobacterium tuberculosis Clinical Isolates.
    PLoS One. 2016;11:e0166052.
    PubMed     Text format     Abstract available


  630. CHEN DY, Li JP, Chen YM, Liao TL, et al
    Elevated Neopterin Levels Are Associated with Increased Tuberculosis Risk in Rheumatoid Arthritis Patients with QuantiFERON Conversion during Biologic Therapy.
    PLoS One. 2016;11:e0166301.
    PubMed     Text format     Abstract available


  631. NOSOVA EY, Zimenkov DV, Khakhalina AA, Isakova AI, et al
    A Comparison of the Sensititre MycoTB Plate, the Bactec MGIT 960, and a Microarray-Based Molecular Assay for the Detection of Drug Resistance in Clinical Mycobacterium tuberculosis Isolates in Moscow, Russia.
    PLoS One. 2016;11:e0167093.
    PubMed     Text format     Abstract available


  632. FATIMA R, Qadeer E, Yaqoob A, Haq MU, et al
    Extending 'Contact Tracing' into the Community within a 50-Metre Radius of an Index Tuberculosis Patient Using Xpert MTB/RIF in Urban, Pakistan: Did It Increase Case Detection?
    PLoS One. 2016;11:e0165813.
    PubMed     Text format     Abstract available


  633. SMITH GC, Delahay RJ, McDonald RA, Budgey R, et al
    Model of Selective and Non-Selective Management of Badgers (Meles meles) to Control Bovine Tuberculosis in Badgers and Cattle.
    PLoS One. 2016;11:e0167206.
    PubMed     Text format     Abstract available


  634. BRONNER MURRISON L, Martinson N, Moloney RM, Msandiwa R, et al
    Tobacco Smoking and Tuberculosis among Men Living with HIV in Johannesburg, South Africa: A Case-Control Study.
    PLoS One. 2016;11:e0167133.
    PubMed     Text format     Abstract available


  635. NIETO R LM, Mehaffy C, Creissen E, Troudt J, et al
    Virulence of Mycobacterium tuberculosis after Acquisition of Isoniazid Resistance: Individual Nature of katG Mutants and the Possible Role of AhpC.
    PLoS One. 2016;11:e0166807.
    PubMed     Text format     Abstract available


  636. NUGENT G, Yockney IJ, Whitford EJ, Cross ML, et al
    Field Trial of an Aerially-Distributed Tuberculosis Vaccine in a Low-Density Wildlife Population of Brushtail Possums (Trichosurus vulpecula).
    PLoS One. 2016;11:e0167144.
    PubMed     Text format     Abstract available


  637. MODI S, Cavanaugh JS, Shiraishi RW, Alexander HL, et al
    Performance of Clinical Screening Algorithms for Tuberculosis Intensified Case Finding among People Living with HIV in Western Kenya.
    PLoS One. 2016;11:e0167685.
    PubMed     Text format     Abstract available


  638. JIANG F, Huang W, Wang Y, Tian P, et al
    Nucleic Acid Amplification Testing and Sequencing Combined with Acid-Fast Staining in Needle Biopsy Lung Tissues for the Diagnosis of Smear-Negative Pulmonary Tuberculosis.
    PLoS One. 2016;11:e0167342.
    PubMed     Text format     Abstract available


  639. GUERRINI V, Subbian S, Santucci P, Canaan S, et al
    Experimental Evolution of Mycobacterium tuberculosis in Human Macrophages Results in Low-Frequency Mutations Not Associated with Selective Advantage.
    PLoS One. 2016;11:e0167989.
    PubMed     Text format     Abstract available


  640. HUNDIE GB, Woldemeskel D, Gessesse A
    Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis.
    PLoS One. 2016;11:e0169188.
    PubMed     Text format     Abstract available


  641. BAEZ-SALDANA R, Delgado-Sanchez G, Garcia-Garcia L, Cruz-Hervert LP, et al
    Isoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010.
    PLoS One. 2016;11:e0168955.
    PubMed     Text format     Abstract available


  642. YEH JJ, Wang YC, Lin CC, Lin CL, et al
    Association of Respiratory Tuberculosis with Incident Bone Fracture: Bridging the Tuberculosis Airway Infection and the Osteoporotic Bone.
    PLoS One. 2016;11:e0168673.
    PubMed     Text format     Abstract available


  643. LAHEY T, Laddy D, Hill K, Schaeffer J, et al
    Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis.
    PLoS One. 2016;11:e0168521.
    PubMed     Text format     Abstract available


  644. ZHANG F, Xu C, Ning L, Hu F, et al
    Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis.
    PLoS One. 2016;11:e0167109.
    PubMed     Text format     Abstract available


  645. CABRERA-GAYTAN DA, Niebla-Fuentes MD, Padilla-Velazquez R, Valle-Alvarado G, et al
    Association of Pulmonary Tuberculosis and HIV in the Mexican Institute of Social Security, 2006-2014.
    PLoS One. 2016;11:e0168559.
    PubMed     Text format     Abstract available


  646. SUN Q, Wei W, Sha W
    Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-gamma Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    PLoS One. 2016;11:e0166501.
    PubMed     Text format     Abstract available


  647. DEKHIL N, Meftahi N, Mhenni B, Ben Fraj S, et al
    MDR-TB Outbreak among HIV-Negative Tunisian Patients followed during 11 Years.
    PLoS One. 2016;11:e0153983.
    PubMed     Text format     Abstract available


  648. KJAERGAARD J, Stensballe LG, Birk NM, Nissen TN, et al
    Lack of a Negative Effect of BCG-Vaccination on Child Psychomotor Development: Results from the Danish Calmette Study - A Randomised Clinical Trial.
    PLoS One. 2016;11:e0154541.
    PubMed     Text format     Abstract available


  649. TAI MS, Sharma VK
    Role of Transcranial Doppler in the Evaluation of Vasculopathy in Tuberculous Meningitis.
    PLoS One. 2016;11:e0164266.
    PubMed     Text format     Abstract available


  650. BIAN S, Zhang Y, Zhang L, Shi X, et al
    Diagnostic Value of Interferon-gamma Release Assays on Pericardial Effusion for Diagnosis of Tuberculous Pericarditis.
    PLoS One. 2016;11:e0165008.
    PubMed     Text format     Abstract available


  651. WEI W, Wei-Sheng Z, Ahan A, Ci Y, et al
    The Characteristics of TB Epidemic and TB/HIV Co-Infection Epidemic: A 2007-2013 Retrospective Study in Urumqi, Xinjiang Province, China.
    PLoS One. 2016;11:e0164947.
    PubMed     Text format     Abstract available


  652. MENG Q, Sayin I, Canaday DH, Mayanja-Kizza H, et al
    Immune Activation at Sites of HIV/TB Co-Infection Contributes to the Pathogenesis of HIV-1 Disease.
    PLoS One. 2016;11:e0166954.
    PubMed     Text format     Abstract available


  653. HESLOP R, Bojang AL, Jarju S, Mendy J, et al
    Changes in Host Cytokine Patterns of TB Patients with Different Bacterial Loads Detected Using 16S rRNA Analysis.
    PLoS One. 2016;11:e0168272.
    PubMed     Text format     Abstract available


  654. GILBERT JA, Shenoi SV, Moll AP, Friedland GH, et al
    Cost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South Africa.
    PLoS One. 2016;11:e0165614.
    PubMed     Text format     Abstract available


  655. BROPHY JC, Hawkes MT, Mwinjiwa E, Mateyu G, et al
    Survival Outcomes in a Pediatric Antiretroviral Treatment Cohort in Southern Malawi.
    PLoS One. 2016;11:e0165772.
    PubMed     Text format     Abstract available


  656. KILALE AM, Ngadaya E, Muhumuza J, Kagaruki GB, et al
    Who Has Mycobacterial Disease? A Cross Sectional Study in Agropastoral Communities in Tanzania.
    PLoS One. 2016;11:e0153711.
    PubMed     Text format     Abstract available


  657. HANIFA Y, Fielding KL, Chihota VN, Adonis L, et al
    Diagnostic Accuracy of Lateral Flow Urine LAM Assay for TB Screening of Adults with Advanced Immunosuppression Attending Routine HIV Care in South Africa.
    PLoS One. 2016;11:e0156866.
    PubMed     Text format     Abstract available


  658. VELEN K, Lewis JJ, Charalambous S, Page-Shipp L, et al
    Household HIV Testing Uptake among Contacts of TB Patients in South Africa.
    PLoS One. 2016;11:e0155688.
    PubMed     Text format     Abstract available


  659. MEGHJI J, Simpson H, Squire SB, Mortimer K, et al
    A Systematic Review of the Prevalence and Pattern of Imaging Defined Post-TB Lung Disease.
    PLoS One. 2016;11:e0161176.
    PubMed     Text format     Abstract available


  660. SHENAI S, Ronacher K, Malherbe S, Stanley K, et al
    Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB.
    PLoS One. 2016;11:e0160062.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: